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Rapidly progressive glomerulonephritis type Ill with positive anti.
cytoplasmatic antibodies (C.ANCA).—A variant of disease? D. Bach, P.
Heering, U. Helmchen, W.L. GroJi, B. Grabensee, Department of
Nephrology, Heinrich Heine University, Düsseldorf, Department of
Pathology, Hamburg University, Department of Clinical Rheumatol-
ogy, Lflbeck University, Germany. The so-called rapidly progressive
glomerulonephritis (RPGN) is clinically characterized by a rapid renal
insufficiency. The RPGN type III has come into the center of interest,
as the positive proof of anti-cytoplasmatic antibodies against neutrophil
granulocytes (C-ANCA) gives diagnostic hints for the presence of renal
vasculitic manifestation. We report on 11 patients (5 f, 6 m; mean age
53.2 years) who clinically presented with an idiopathic RPGN. All
patients had a positive C-ANCA titer, apart from kidney disease; no
features of vasculitis were found. The percentage of necrotic glomeruli
ranged between 3.8% and 90.9%. All patients were treated with
methylprednisolone pulse therapy and cyclophosphamide; 5 patients
underwent additional plasmaseparation therapy. Four patients are now
on chronic haemodialysis and 7 patients have a moderate renal insuffi-
ciency. Conclusions: (1.) Positive C-ANCA titers lead to a diagnosis of
renal vasculitis manifestation in the so-called idiopathic RPGN. (2.) An
early histological proof provides a successful immunosuppressive ther-
apy. (3.) A high percentage of floride necrotic glomeruli implies a
relatively good prognosis.
Quantitative analysis of brush border proteins from renal proximal
tubule in urine of healthy subjects. H.-W. Birk, G. Schütterle, H.
Koepsell, Medizinische Klinik II, .Justus-Liebig Universitflt Giessen
and Max-Planck Institut für Biophysik FrankfurtlM., Germany. The
quantitative analysis of kidney derived antigens in the urine might
become an important procedure for an early differential diagnosis of
kidney malfunction. Prerequisite is the characterization of urinary
antigen excretion in healthy subjects. To this end a sensitive solid-phase
radioimmunoassay was established which permits the simultaneous
quantification of different antigens in normal urine. Urinary antigens are
immobilized on nitrocellulose membrane and reacted with different
monoclonal antibodies. Detection of bound antibodies is performed by
incubation with a cascade of species-specific antisera, employing an
'25iodinated fraction in the last step. The excretion of the renal
Na-D-glucose cotransporter (microvillar membrane) in normal urine
was analyzed in comparison with the excretion of two further, differ-
ently localized proteins of the proximal tubular brush border, a kidney-
specific 400 kD glycoprotein (intervillar membrane) and villin (microvil-
lar core). The daily excretion of these proteins varied considerably
between individuals, but was positively correlated with one another.
This indicates a common mechanism for the liberation of the brush
border proteins during the physiological membrane turnover.
Interaction between organic cation and anion transport at the basolat-
eral membrane of rabbit proximal tubule. E. Brandle and J. Greven,
Department of Pharmacology, R WTH Aachen, Wend/ingweg, Aachen,
Germany. In a previous study we could demonstrate active transport of
cimetidine across the basolateral membrane of rabbit proximal tubule.
The transport system accepted only the positively charged cimetidine.
Effiux exchange studies provided evidence that cimetidine shares a
common transport system with a number of organic bases. This lead us
to conclude that cimetidine characterizes the transport system of
organic cations. However, McKinney (Am J Physiol l0:F69—F76, 1981)
reported an inhibition by probenecid of cimetidine secretion in isolated
perfused proximal tubules also, suggesting an interaction between
organic anion and cation transport in the kidney. The aim of the present
study was to examine the interaction between organic anions and
cations at the basolateral membrane of the isolated, non-perfused rabbit
proximal tubule. S2 segments of proximal tubules were incubated at
37.5°C with 3H-cimetidine (2 l0 mollliter) or 3H-PAH (4 . l0_6
mollliter) and '4C-inulin (marker for the extracellular space) for 25 mm
to achieve a steady state. Afterwards, a non-radioactive test substance
was given to the bath and the change of the intracellularly stored
radioactivity was measured in time intervals of 5 mm. The data given
are the values obtained 25 mm after adding the test substance. Effiux
exchange of 3H-cimetidine: Probenecid at 5 10 mol/liter decreased
the intracellular amount of cimetidine by 74%. At this concentration,
furosemide and Na2SO4 had no effect. At a concentration of lO
mol/liter these substances, however, decreased cellular cimetidine
uptake by 67% (furosemide) and 43% (Na2SO4). Effiux exchange of
3H-PAH: At concentrations of iO mol/liter the organic bases cimeti-
dine, N-methyl-nicotinamide and quinine decreased the intracellular
amount of PAH by 48%, 42% and 83%, respectively. Cimetidine and
N-methyl-nicotinamide were also tested at a concentration of S lO
mol/liter. At this concentration no effect was observed. Conclusion:
The results indicate that the transport of organic cations across the
basolateral membrane of rabbit proximal tubule can be inhibited by
organic anions and vice versa. With the exception of probenecid this
interaction, however, can only be demonstrated at high inhibitor
concentrations (l0 mol/liter).
Renal function and the therapy of severe congestive heart failure
(NYHA III.IV) with short or long acting ACE inhibitors. U.A. Braun,
HG. Klärner, W. Muller-Schauenburg, H.C. Heitkamp, C.G. Brilla,
B.K. Kramer, T. Risler, Medizinische Klinik, Abt. III und Abt. Sport-
medizin, sowie Radiologische Klinik der Universität Tflbingen, Ger-
many. In a randomized, cross-over designed study, 12 patients with
severe congestive heart failure (NYHA class III-IV) were treated with
a short or long-acting ACE inhibitor, captopril, 3 x 12.5 mg or lisinopril
1 x 5 mg, respectively. Both drugs were given three months, inter-
rupted by a wash-out period of three days. Only patients with arterial
hypotension, renal impairment or diabetes mellitus were admitted to the
study. Follow-up evaluation of renal parameters and humoral changes
as well as exercise tolerance showed significant improvement on
cardiac function in both therapies; renal function was not affected.
Captopril had less influence on renin, aldosterone and catecholamines
than lisinopril, whereas microproteinuria was more pronounced with
captopril. Hypotension, as well, seemed to be a greater problem with
captopril than with lisinopril. These results, however, are not statisti-
cally significant. In conclusion, in high risk patients with severe heart
failure, therapy with long-acting ACE inhibitors did not show any
disadvantage compared to the treatment with short-acting ACE inhib-
itors.
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Role of the nonenzymatically glycosylated albumin for the diabetic
nephropathy. I. Bundschuh, I. JackIe-Meyer, E. Luneberg, R. Petzoldt,
1299
1300 Abstracts
C. Bentzel, H. Stolte, Division of Nephrology, Medical School Han-
foyer, and Diabetesklinik, Bad Oeynhausen, Germany; East Carolina
University, School of Medicine, Renal Division, Greenville, USA. A
well known parameter of diabetes mellitus is the enhanced nonenzy-
matic glycosylation of serum albumin. The present study was designed
to investigate if the microalbuminuria of the beginning diabetic
nephropathy can be explained by this protein modification. Further, the
excretion of glycosylated albumin into the urine was examined to
determine the relationship between the amount of the excreted glyco-
sylated albumin and the development and progression of the diabetic
nephropathy. Third, the role of cationized albumin was studied, be-
cause of the hypothesis by Ghiggeri GM, et a! (1984), to provide an
explanation for the microscopic albuminuria of early diabetes. Results:
(1.) The diabetic patients (type I and type II diabetes mellitus) were
divided into groups according to their albumin excretion rates: group I,
diabetes with a normal albumin excretion rate (N = 30, 3i = 4.2 mg/12
hr), group II, diabetics with microalbuminuria (N = 17, 5 = 38.6mg/12
hr); group III, diabetics with overt albuminuria (N = 21, = 582.5
mg/12 hr). (2.) The percent of glycosylated albumin in serum (Glyco Gel
Test Kit) was, in group I (T = 3.2%), group II ( = 4.2%) and group III(T = 3.8%), significantly higher (2 a = 0,01) than in the controls (N =
17, 3 = 1.4%). There was no significant difference between the three
groups. (3.) As far as the renal excretion of glycosylated albumin was
concerned (Glyco Gel Test Kit, ELISA), the amount of glycosylated
albumin in the urine of the controls and group I was beneath 10 ng/ml,
in group II only 0.02% glycosylated albumin were measured, in group
III 0.08%. (4.) The isoelectric focusing and the chromatofocusing
revealed the native albumin with a p1 at 4.7 and an anionic albumin
fraction with apI at 3.5—4.0. There was no cationized albumin with a p1
over 4.7. In vitro glycosylated human serum albumin showed the same
pattern. Conclusions: Microscopic albuminuria of early diabetes cannot
be explained by cationized albumin. The amount of glycosylated
albumin found in the urine is too descrete to indicate the development
and progression of diabetic nephropathy. Still, the microalbuminuria is
an important predictor of the beginning diabetic nephropathy, although
nonenzymatic glycosylation of albumin is not an explanation.
Ten years continuous peritoneal dialysis (CAPD) as an integrated
method in the treatment of diabetics with end-stage renal disease. H.
Chlebowski, M. Koch, F.W. Kemmer, P. Heering, B. Grabensee,
Heinrich Heinrich-University Düsseldorf, Department of Nephrology,
Düsseldorf, Germany. CAPD is recommended as a first class treatment
for patients with diabetic nephropathy as a long-term treatment or as a
renal replacement therapy until receiving a kidney graft. This study
examined 55 diabetics (45 type I, 9 type II), 39 male, 16 female (age: 46
14 years). The patients had a mean diabetes duration of 20 + 19 years
before starting CAPD. Mean time on CAPD was 20 17 months.
Cumulative treatment was 93 years. Results: We saw a significant
increase in hemoglobin (9.2 1.5/il 1.8) after 12 months without
EPO. The blood pressure didn't change although antihypertensive
medication could be reduced. There was no change in cholesterol, hdl
and ldl. An initial increase in triglycerides was reversed after 24
months. There was a rise in HbA1 from 7,39 0.88% initially to 8.36
1.4% after 24 months, declining afterwards. Insulin application was
done exclusively s.c. There was a significant increase in body weight
(64 3.2/75 2.2 kg) after 48 months. Diabetic retinopathy worsened
in 9% of our patients. Limb amputation was necessary in 4 patients. The
survival rate was 82% for the first year. Main reason for death were
cardiovascular complications. The probability for the first peritonitis
was 75% after 25 months on CAPD. Seven patients received a kidney
graft and 9.3% were transferred to hemodialysis after peritonitis.
Conclusions: (1.) CAPD is a competitive renal replacement therapy in
the treatment of diabetics with end-stage renal disease. (2.) Although
there is a steady glucose loading, lipid and glucose metabolism are
stable. (3.) CAPD can be recommended especially to younger diabetics
with ESRD, waiting for a kidney graft.
Efficacy of clindamycin in peritonitis with intracellular staphylococci
during CAPD. H. Chlebowski, J. Passlick-Deetfen, A. Gehrt, B. Grab-
ensee, Heinrich Heine-University Düsseldorf, Department of Nephrol-
ogy and Department of Microbiology, Düsseldorf, Germany, Peritonitis
remains the main complication of continuous ambulatory pentoneal
dialysis (CAPD). Two thirds of all episodes are caused by staphylo-
cocci. Peritonitis resistant to antibiotic therapy together with tunnel
infections and recurrent infections of the exit-site are the main reasons
for discontinuing CAPD. Results: We report 7 episodes of staphylo-
cocci peritonitis in 5 patients (1985—1989, overall peritonitis episodes
92). In all 7 episodes the peritonitis showed a poor response to i.p.
administered oxacillin, although this was in vitro highly efficient against
the staphylococci. In all cases there was a decrease in peritoneal white
cell count and a relapse of peritonitis within days. In all cases
intracellular staphylococci could be diagnosed. After changing the
antibiotic therapy to clindamycin (900—1200 mg/day, i.p.) peritonitis
resolved within 15 days (mean). All patients remained on CAPD. No
catheter had to be exchanged. Conclusions: (1.) Diagnosis and therapy
of peritonitis should not be based only on the in vitro measured efficacy
of an antibiotic. It should also include the microscopic investigation of
the peritoneal effluate cell centrifugate. (2.) After diagnosing intracel-
lular staphylococci therapy should be changed to an antibiotic which
provenly penetrates peritoneal macrophages, (3.) There is a fast resolve
of peritonitis without the need of discontinuing CAPD.
Captopril test and renal scintigraphy in the screening for hypertensive
bilateral renal artery disease. S. Degenhardt, 0. Langer, A. Linden, W.
Gross-Fengels, Medizinische Klinik II, Instil Ut für Nuklearmedizin und
Institut für Radiologie der Universität zu Köln. Captopril-stimulated
plasma renins can be misleadingly low when bilateral renal artery
stenoses (RASt) or stenosis of a single kidney are present. We studied
299 hypertensives with angiographically proven RASt (1/1/85 to 2/28/
1990, University of Cologne Hospital and City Hospital Koln-Mer-
heim). Two hundred and five (68.8%) patients had unilateral RASt, 84
(28.1%) had bilateral RASt, 4 (1.4%) had RASt of a single kidney and 6
(2%) RASt of a transplant kidney. In 29 of 94 patients with non-
unilateral RASt a captopril test had been done. Fourteen of 29 (48.3%)
had increased basal or stimulated plasma renins, 15/29 (51.7%) were
overlooked by the captopril test (cutoff values for plasma renin concen-
tration: basal >40 U/mI, 1 hr after captopril >180 U/mI). On renal
scintigraphy patients not discovered by the captopril test had reduced
overall clearances (8/15 = 53.3%) or a difference between kidneys of
>15% (11/15 = 73.3%) or both (4/15 26.6%). Although the captopril
test detects hypertension caused by unilateral RASt, its low sensitivity
for the detection of bilateral renal artery disease of about 50% makes it
unsuitable to be the only screening test. Hypertensives with renovas-
cular hypertension but renin suppression by volume overload generally
have reduced overall kidney function or a difference in clearances
between kidneys indicated by renal scintigraphy. Thus, the combina-
tion of captopril testing with renal scintigraphy identifies those patients
in whom a renovasography for the final diagnosis of hypertensive
renovascular disease is mandatory.
Value of renal biopsy during the first 8 weeks after kidney transplan-
tation. G. Ditscherlein, T. Mühlberg, U. StOtzer, U. Strobelt, D.
Scholz, Institute Pathology, Humboldt University, Kidney Transplant
Center, Friedrichshain, Berlin, Germany. Graft biopsies were done
only in cases with differential diagnostic difficulties. Assessment of 150
successful biopsies (from ill patients) brought these results: in 22%
morphological findings of acute renal failure (so-called acute tubular
necrosis) with dilated tubules were found, but only in a few cases with
wide-spread necroses. In 75% acute interstitial rejection (R) was
observed, and about 4/5 of these were of moderate degree. In 40% we
saw an acute vascular R, in most cases in combination with interstitial
R. Only in 15% was isometric vacuolization of proximal tubular cells
seen that was suggestive of cyclosporine toxicity, while other lesions of
toxic origin were missed. A comparison between certain clinical groups
and histological diagnoses showed a higher percentage of morphological
signs of acute renal failure in the group which had been primarily
without renal function after transplantation. There was no further
correlation between the supposed clinical diagnoses on the one hand
and histological findings on the other. Our results emphasize the value
of renal biopsy for therapy and prognosis.
Antibodies (ANCAs) against myeloperoxldase and a 29 kD antigen
(proteinase 3) discriminate between different vasculitides. S. Eber-
shduser, S. Apenberg, K. Andrassy, R. Waldherr, Departments of
Medicine and Pathology, University of Heidelberg, Heidelberg, Ger-
many. Diagnosis of Wegener's granulomatosis (WG) and related disor-
ders has been improved with the introduction of ANCAs. ANCAs can
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be detected by indirect immunofluorescence or ELISA. Antibodies
against a 29 kD antigen are associated with the classic diffuse, fine
granular cytoplasmatic staining (C-ANCA) on ethanol fixed neutro-
phils, whereas perinuclear staining (P-ANCA) may be caused by
myeloperoxidase antibodies (MPO-ab) and are typical of microscopic
polyarteritis. As a referral center for WG we investigated 2450 sera
from patients during a 12 month period. Patients with collagen vascular
disease were excluded. Seventy patients (22 m, 48 1) had MPO-ab (9/70
with concomitant low titer 29 kD-ab) and 172 patients (105 m, 67 f) had
29 kD-ab (9/70 with concomitant low titer MPO-ab). RPGN was
diagnosed in 42/70 patients with MPO-ab (median 23.3; 3.1-131; NV 2),
and biopsy confirmed crescentic GN in 33/42 patients. Renal arteritis
was present in 13/33 patients. In patients with 29 kD-ab (median 43;
15-240; NV 10) RPGN was diagnosed in 60/172 patients and biopsy
confirmed crescentic GN in 39/60 patients. Renal arteritis was observed
in only 1/39 patients. Renal arteriolitis, however, was frequent in
patients with 29 kD-ab as well as with MPO-ab. Conclusion: MPO-ab
are linked to the female sex and define a more severe renal lesion than
observed in patients with 29 kD-ab.
Mesangial cells (MCs) in culture express a-smooth muscle actin. M.
Engler, R. Nobiling, D. Drenckhahn, W. Kriz, Departments of Anat-
omy and Physiology, Universities of Heidelberg and Marburg, Ger-
many. It is widely assumed that MCs actively contribute to the
regulation of the glomerular filtration rate because of their contractile
ability observed in culture (Kreisberg et al, Am J Physiol 249:F457,
1985). However, the relevance of mesangial contraction is under
debate. To characterize the actin content of MCs, a monoclonal
antibody against alpha-smooth muscle actin (anti-a-sm-i; Skalli et al, J
Cell Biol 103:2787, 1986), an isoform present in high amounts in
vascular smooth muscle cells (VSMCs) was used. The occurrence of
a-actin was studied in native cryostate sections and aidehyde-fixed 1
sm semithin sections of kidneys and in cultured MCs by indirect
immunofluorescence. In sections of the kidney cortex, anti-a-sm-i
intensely labelled the VSMCs of arteries, arterioles, and veins. Glomer-
ular cells including MCs were not reactive. A faint reactivity of few
cells was observed in the wall of the intraglomerular segment of the
efferent arteriole. In contrast, MCs in culture showed bright fluores-
cence in 50 to 90% of the cells treated with anti-a-sm-l. The high
percentage of cells was found in primary cultures and all passages (up to 9
investigated). In conclusion, MCs in culture—in contrast to those in
vivo—express a-actin. The well known isotonic contractility of cultured
MCs may therefore depend on the expression of a "foreign" actin.
Effect of advanced glycation end products on metabolism of basement
membrane collagen in diabetic rats. K. Engelmann, C. Hasslacher, V.
GOnzler, H.P. Kempe, Heidelberg/Frankfurt, Germany. Advanced
glycation end products (AGE) may influence metabolism of type IV
collagen (IVC) by (a) alteration of enzymes or regulatory proteins
involved in synthesis or degradation or by (b) changes of the molecular
structure of this protein. We investigated the effect of aminoguanidine
(AG), an inhibitor of AGE formation, on metabolism of IVC in diabetic
rats (DR), which received AG in drinking water over 12 weeks. Serum
concentration of IVC was measured radioimmunologically using two
different antigens: non-collagenous domain 1 (Nd), which represents
IVC synthesis and 7S-collagen (7SC), which additionally detects deg-
radation products. Thus, the ratio of 7SC/NC 1 levels gives information
on the balance between synthesis and degradation of IVC. Compaired
with nondiab. controls, 75C and NC1 were elevated in untreated DR
[blood glucose 21.4 1.9 mmol/liter (mean SD)] to a different extent;
ratio changed from 0.64 to 1.06. Insulin treatment of DR [6 1
mmollliter] normalized both 7SC and NC! levels (ratio 0.60). In
AG-treated DR [19.3 1.8 mmollliter] 7SC levels were lowered;
however, NC! levels remained elevated (ratio 0.85). These results
indicate that AGE are not a reason for overproduction of IVC but may
be involved in degradation of this protein.
Vascular complement activation, adhesion molecules and cell-mediated
rejection in kidney allografts. HE. Feucht, E. Felber, f.M. Gokel, G.
Hillebrand, U. Nattermann, C. Brockmeyer, G. Riethmüller, W. Land,
E. Albert, Med.Klinik Innenstadt, Inst .f.Immunologie, Inst.f.Patholo-
gie, Med.Klinik I, Abtlg.f.Transplantationschirurgie, Klinikum Gro-
Jihadern, Med. Kinderpoliklinik; Universität München, Germany. Com-
pared to the well defined cell-mediated and less well defined antibody-
mediated allograft reactions, surprisingly little information is available
concerning activation of the complement system during rejection.
Therefore, a panel of monoclonal antibodies reactive with various
complement split products was used in an indirect immunoperoxidase
staining technique for the investigation of 60 renal transplant biopsies.
Intense deposition of complement fragments C4d and C3d, indicating
activation of the classical pathway, could be detected in peritubular
capillaries in the majority of transplanted kidneys with immunological
rejection. Complement activation was abundant in 15 early transplant
biopsies from patients at high 'immunological risk' (i.e. patients with
previous transplants andlor with circulating antibodies against HLA-
antigens). Despite negative results in the cross match prior to transplan-
tation and paucity of immunoglobulins in transplant biopsies, antibodies
directed against minor HLA or endothelial cell antigens have to be
considered causative for abundant classical complement activation. The
accumulation of mononuclear cells carrying CD! lb/CD18 adhesion mole-
cules (complement receptor type 3) in and around peritubu!ar capillaries
suggests a functional role of vascular complement activation for the
promotion of cellular rejection. The results provide evidence that humoral
and cellular immune mechanisms might interact much closer in the course
of acute allograft rejection that has been recognized so far.
Induction of MHC-class II antigens on cultured human tubular epithe-
hal cells by gamma-interferon. J. Frank, C. Muller, K. Haist, C. Boss,
H.-J. Buhring, G.A. Muller, Medical Clinics, Departments II and III,
University of Tubingen, 7400 Tubingen, Germany. An abnormal expres-
sion of MHC class II antigens (HLA-DQ, -DR, -DP) on proximal
tubular epithelial cells (PTECs) was described in different forms of
glomerulonephritis. For functional analysis, renal tubular epithelial
cells were kept in culture. Cells were derived from 5 renal biopsies and
1 donor cadaver kidney which was offered for transplantation, Cells
were grown in DMEM supplemented with antibiotics and 20% FCS in
the primary cultures, 10% FCS in all the following secondary cultures.
The growth rate of the PTECs decreases after the first two passages and
their growth ends after the 5th to 6th passage. Cultured PTECs were
characterized with monoclonal antibodies of the TN-series, detecting
different renal antigens. FACS analysis revealed that primary cultures
of PTECs did not express MHC class II antigens. After the addition of
gamma-interferon in concentrations of 1000 and 500 U/mI culture
medium PTECs expressed HLA-DR antigens after 48 hrs. Seventy-two
hrs after the addition of gamma-interferon the PTECs were also positive
for HLA-DQ and HLA-DP. These results suggest that PTECs may
interact with T cells in local immune response and perhaps play a role
in the presentation of antigens.
Cytokine and proliferation dependent IL-6 secretion of human glomer-
ular mesangial cells (HMC). H.H. Radeke, M. Germer, J. Von Der Ohe,
K. Resch, Department of Molecular Pharmacology, Medical School,
Hannover, Germany. Recent studies have demonstrated that human
mesangial proliferative glomerulonephritis is characterized by urinary
IL-6 excretion and mesangial IL-6 expression. We studied IL-6 secre-
tion of cultured HMC measuring the IL-6 dependent proliferation of the
mouse B-cell hybridoma, 7TD1 (van Snick) after 72 hrs incubation by
MTT staining. The specificity of this cell line for mouse and human IL-6
was further confirmed. However, as fetal calf serum dose dependently
activated 7TD1 cells, HMC stimulation and subsequent IL-6 assays
were performed at constantly 1% FCS. Unstimulated HMC constitu-
tively secreted IL-6 bioactivity and dilutions down to 1:512 caused
significant 7TD1 proliferation. This corresponds to an IL-6 activity of
100 U/mI equivalent to I ng/ml rhIL-6. To analyze the effect of different
stimuli in series of experiments we calculated a stimulation index (S.I.,
i.e., the 7TDI growth stimulation induced by a 1:16 dilution of HMC
supernatants divided by the respective assay control). IL-l/3 (25 ng/ml)
stimulation of HMC for 2, 4, 8, 12, 24, 48 hrs significantly increased
IL-6 secretion after 8 hrs (5.09 0.79 SI. vs. 1.87 0.05 S.I. of
unstimulated HMC). The peak response towards IL-lf3 (25 ng/ml) and
TNFa (10 ng/ml) was measured after 24 hrs, being 6.58 0.91 S.I. and
2.56 0.24 SI., respectively. Combinations of IL-l/3 and TNFa
resulted in a marked synergistic induction of IL-6 especially at lower
concentrations. IL-1f3 (12.5 ng/ml) gave a S.1. of 3.32 0.57, TNFa (5
ng/ml) 1.33 0.05, whereas the combination resulted in 9.19 1.01 S.I.
Other potent activators of IL-6 secretion by HMC were PDGF-BB, IL-! a,
TNFa//3, LPS and IFN-gamma, whereas IL-2 and supernatants of stimu-
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lated Jurkat cells had no effect on IL-6 secretion. In conclusion, the high
basaJ IL-6 production of HMC possibly correlated to the proliferative
status could be further enhanced by monocyte factors. This may be
important for the progression of human mesangioproliferative GN.
Pharmacokinetics and dynamics of cisapride in hemodialysis (HD)
patients. U. Gladziwa, R. Bares, B. Schacht, K.V. Dakshinamurty,
K.-U. Seiler, H. Mann, U. Bull, H.-G. Sieberth, Departments of
Internal Medicine II and Nuclear Medicine, Technical University of
Aachen, Aachen, Germany. The pharmacokinetics and dynamics of
cisapride (Cis), a new prokinetic substance, were studied in hemodial-
ysis patients before, during and after the hemodialysis session (HD).
Eight patients received 20 mg Cis orally 15 minutes before meal, 12
hours before the start of HD, and immediately after HD, respectively.
In plasma, dialysate, and urine Cis was estimated with a specific and
sensitive HPLC method, and Nor-Cis with gas chromatography. In 6
HD patients, we determined the gastric half-emptying time in a cross
over comparative study with and without Cis medication in steady
state, by scintigraphy using Tc-99m labelled hard boiled eggs. Results:
After oral ingestion Cis was eliminated with a half-life of 10.1 3.5 hr( so) and a total clearance of 383 138 ml/min. The distribution
volume was 4.88 3.77 liter/kg. In dialysate the metabolite Nor-Cis
only was eliminated (0.36 0.067 mg). Cis was not traceable. The
gastric emptying was clearly accelerated under Cis medication (t50% cis
= 21.5 vs. 41.2 mm). Conclusions: The results are comparable with the
data from control patients without renal disease. Additional ingestion of
Cis after HD is not necessary, Cis normalizes the abnormal gastric
motility in dialysis patients.
Morphological findings In renal transplant biopsy specimens in relation
to immunosuppressive therapy. T. GroJimann, H. V. Gartner, H. Bayer-
Helms, M. Wehrmann, W.D. Schareck, Institute of Pathology and
Department of Surgery, University of Tflbingen, Tubingen, Germany.
The type and intensity of rejection play a critical role in the prognosis
of the renal transplant. The nephrotoxicity of cyclosporin A (CsA) has
to be weighed against the improvement in graft function that can be
achieved with this agent. To determine the influence of CsA two
different CsA treatment protocols and conventional immunosuppres-
sive therapy were compared. The study included 48 patients, all of
whom exhibited an episode of rejection within six weeks of transplan-
tation: immunosuppressive therapy consisted of cortisone, azathio-
prine, and antithymocyte globulin (ATG) in 19 (conventional therapy),
cortisone and CsA in 13, and triple therapy comprising CsA, azathio-
prine, and cortisone in 16. Clinical and laboratory details of the donor,
and laboratory, clinical, and scintigraphic evidence of rejection were
compared with morphological findings in the kidney. For each case, the
severity of interstitial rejection and especially the composition of the
cellular infiltrates in the renal interstitium were evaluated. The groups
showed no significant differences with respect to the total number of
cellular infiltrates, but were significantly different with respect to the
quantity of the T cell population. So the group treated with cortisone
and CsA showed a significantly greater number of infiltrating T cells: 35
cells per high-power field compared with 22 and 16 in the other groups.
Moreover, this group exhibited a poorer long-term outcome: only 69%
as opposed to 84% (conventional therapy) and 88% (triple therapy) still
had a functioning graft at one year. In summary, it was found that in
patients exhibiting graft rejection within six weeks of transplantation,
the results of conventional immunosuppressive therapy are good; as far
as renal morphology and long-term function are concerned, CsA in form
of triple therapy application gives markedly better results than CsA and
cortisone alone. Triple therapy provides adequate immunosuppression
with good long-term function.
Regulation of the organic osmolytes sorbitol, glycerophosphorylcholine(GPC), and inositol in the renal inner medulla of diabetic rats. R. W.
Grunewald, f.M. Grunewald, H.E. Franz, Sektion Nephrologie, Abt.
Innere Medizin I, Universitdt Ulm, Ul,n, Germany. Alterations in
metabolism of intracellular organic osmolytes are thought to be partly
responsible for the development of late diabetic complications in
several tissues, e.g., the increase of sorbitol content in the eye lense
seems to be correlated to diabetic cataract, or the decrease of inositol
content in peripheral nerve cells to polyneuropathia. Since papillary
necrosis is often associated with diabetes the composition, the metab-
olism, and the osmoregulation of the main organic osmolytes (sorbitol,
GPC, and inositol) were investigated in the renal inner medulla of
diabetic male Wistar rats. Diabetes was induced by a single intraperi-
toneal injection of streptozotocin (100 mg/kg body wt) and all investi-
gations were done 8 to 12 weeks after treatment. In the homogenate of
the inner medulla the osmolytes were determined enzymatically: sor-
bitol content was found to be increased [99 19 molIg protein in
control (C) vs. 187 4 mol/g in diabetes (D); P < 0.001] whereas the
content of GPC [233 22 prnol/g (C) vs. 223 4 mol/g (D)} and
inositol [91 18 molIg (C) vs. 99 12 mol/g (D)] remained
unchanged. Thus the total content of these organic osmolytes in the
inner medulla of diabetic rats was elevated by 20% up to 509 mOsmlkg.
Since the urine osmolarity (1268 299 mOsm/liter (C) vs. 1366 66
mOsm/liter (D); NS) and the membrane permeability were found to be
unaltered, it was investigated as to whether this total increase was
caused by an altered metabolism of the organic osmolytes: sorbitol
synthesis was increased 4.8-fold up to 51 6 moUg x hr, GPC and
inositol net synthesis (calculated as difference of synthesis and degra-
dation) remained unchanged. These results suggest that the total
intracellular amount of organic osmolytes is elevated in diabetes
irrespective of extracellular osmolarity. This could indicate a disturbed
osmoregulation of inner medullary collecting duct cells in diabetes.
Prostaglandin E2 production of renal papillary interstitial and collect-
ing duct cells. CT. Grupp, D. Cohen, S. Langhans, H.-E. Franz,
Section of Nephrology, University of Ulm, Ulm, Germany. To inves-
tigate the role of prostaglandins (PG) in renal papilla, we compared
PGE2 production of primary cultures (5 days old) of highly purified
(>95% purity) rat interstitial (IC) and collecting duct (PCD) cells. Cells
were directly isolated from papillary cell suspensions by differential
centrifugation and the use of lectin coated beads. IC and PCD cells or
Contaminations by cells of the endothelium and thin limb of Henle's
loop were identified by immunological and morphological criteria, their
ability to bind lectins and their content of lipid droplets, The basal PGE2
production of IC cells was 30 8.7 ng PGE2/mg prot./hr; it was
stimulated by angiotensin II (Ang, 50 nM) 130 26%, by arginine
vasopressin (AVP, 1 /LM) 107 26% and bradykinin (BK, 100 nM) 154
39%. The basal PGE2 production of PCD cells was 128 24 ng
PGE2/mg prot./hr. To examine the side effects of PGE2 release, PCD
cells were cultivated on permeable polycarbonate filters (r = 245 17
ohm ' cm2, PD = —0.97 0.2 my); 76 5% of the POE2 was secreted
into the contraluminal medium. By addition of BK it increased by 55
21%; the stimulations by AVP (26 16%) and ANG (25 18%) were not
significant. The release via luminal membrane was not affected by these
substances. In contrast to cortical collecting duct cells (J Clin Invest 74:63,
1990) PCD cells show in PGE2 secretion. Elucidation of the exact
localization and differentiated regulation of PG synthesis may be of great
importance to understand their physiological function in the papilla.
Estimation of the risk of thrombosis under treatment of renal anemia
with recombinant human erythropoietin (rHuEPO). P. Griitzmacher, M.
Bergmann, T. Tsobanelis, J. Viachojannis, K. Breddin, W. Schoeppe,
St. Markus and University Hospital, Frankfurt/Main, Germany, and
University Hospital Patras, Greece. The risk of thrombosis during
rHuEPO has been a subject of major clinical concern. In the present
study, the influence of rHuEPO on thrombocyte function and plasmatic
coagulation was investigated in 10 anemic RDT pts, treated with
rHuEPO (initial dose 80 U/kg body wt, 3x/wt, i.v.) to achieve a Hct of
30—35%. The maintenance dose was adapted individually thereafter.
Parameters were controlled before, after 2, 4, 6, 8, 12, 12, 18, and 24-52
weeks of rHuEPO therapy (means, a P < 0.05)
Parameters
-
N Before 4 weeks 18—24 weeks
Platelets Xlt'JVpJ 10 216 248 224"
Platelet volumefl 7 11.7 12.3 12.1
Adhesivity index 10 0.74 0.67 0.61
PAT LII 4 16 27 79
Aggregation (collagen) 4 0.40 0.47 0.64"
Aggregation (thrombin) 4 0.25 0.34 0.60"
Fibrinogen mg/dl 10 335 393 425"
Data show an increase in platelets, a slight increase in platelet volume
and an increase in fibrinogen level. Aggregation response to collagen
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and thrombin moderately increases in patients not under aspirin.
Adhesivensess, reduced in uremia, does not markedly change. PTT,Quick, AT III, f VilIc, and v.Willebrand factor remained constant.
Conclusion: Along with an improved platelet function, the increase in
platelet counts and fibrinogen may favor the development of thrombo-
embolic complications under rHuEPO therapy. Prophylactic treatment
with aspirin does not seem necessary in general, but is recommended
for high risk patients.
Treatment of progressive coronary heart disease during maintenance
hemodialysis with additional LDL-pheresis. P. Grützmacher, H.
Scheuermann, C. Vallbracht, W. Schoeppe, 2nd Medical Clinic, St.
Markus Hospital, Departments of Nephrology and Cardiology, Univer-
sity Hospital, Frankfurt/Main, Germany. Hyperlididemia and coronary
heart disease are common findings in ESRD patients. We describe a
39-year-old male maintained by hemodialysis for 4 years. Three vessel
coronary heart disease was successfully treated by transluminal angio-
plasty. Due to rapid progression of coronary atherosclerosis, repeated
angioplasty was necessary with increasing frequency, five times in
total, each successful. (times: 10.83-10.84-11.85-7.86-1.87) In addition,
well controlled hypertension type lib hyperlipidemia was found. Di-
etary and triple drug therapy (f3-sitosterin, bezafibrate, nicotinic acid)
yielded a reduction of total cholesterol from 443 to 332 mgldl, LDL-
chol. 343 to 256 mg/dl and trigl. 285 to 198 mg/dl; HDL-chol. was 36
mg/dl. Under LDL-apheresis lipid levels were lowered effectively:
mean cholesterol was 263 mg/dl pre- and 152 mg/dl post-apheresis.
After initiation of LDL-apheresis no further progression of coronary
heart disease could be detected; after 18 months LDL-apheresis was
stopped and kidney transplantation was performed. Total observation
period of the symptom free patients currently exceeds 40 months
(normal exercise ecg/125 watt). LDL-apheresis was performed lx!
week during dialysis using parallel flow plasmapheresis and heparin!
acetate-LCL precipitation (HELP, Braun-Melsungen, FRG). Conclu-
sion: Our preliminary experience suggests a profound inhibition of
progressive coronary atherosclerosis in a young ESRD patient with
hyperlipidemia by the introduction of LDL-apheresis to regular hemo-
dialysis treatment, enabling successful renal transplantation.
Studies of the origin of urinary fibronectin. W. Gwinner, I. Jackie-Meyer,
H. Stolte, Medical School Hannover, Division of Nephrology, Hannover,
Germany. The determination of the extracellular matrix protein fi-
bronectin (FN) in urine is a new parameter in non-invasively assessing
biochemical and resulting morphological alterations in renal disease.
For diagnostic application in nephrology two basic questions concern-
ing urinary fibronectin excretion must be answered. (I.) Are the
FN-fragments found in final urine of renal origin or are they filtered
from plasma? (2.) To which modifications FN is subjected during
tubular passage? Experiments and Results: To study the renal handling
of FN in the total kidney biotinylated FN (b-FN) was injected (iv.) into
MWF rats with and without adriamycin (ADR) treatment. ADR animals
were used as a model of high glomerular permeability to be sure that, in
this approach, serum concentration of b-FN was sufficiently high so
that this protein was found in urine if it passed through the glomerular
filter. During 5 days serum and urine samples were collected and
examined in immunoblots with a specific detection system for b-FN.
Labeled FN derived from serum was not found in the urine of healthy
animals but unlabeled FN. That means that FN-fragments normally
found in urine are of renal origin. In ADR animals b-FN was detected
in final urine because of the highly elevated glomerular permeability. To
study the handling of FN in the single nephron, micropuncture exper-
iments at early proximal and distal tubules were performed. They did
not reveal differences in FN-pattern along the nephron and in compar-
ison to final urine. This points to the glomerular origin of urinary
FN-fragments. Conclusions: (I.) Urinary FN-fragments excreted under
physiological conditions are of renal origin. (2.) The pattern of FN-
fragments is not altered during tubular passage. It is therefore con-
cluded that the FN-fragments excreted in urine are of glomerular origin
and that they reflect the turnover of FN in glomeruli.
Peritoneal permeability for proteins and tumor necrosis factor (TNF)
in uninfected CAPD patients. H. Ham, A. Jörres, G. Gahl, A. Pustelnik,
C. Muller, E. Kdttgen, Berlin, Germany. The current study evaluated
peritoneal transport characteristics comprising peritoneal equilibration
tests of low-molecular weight solutes as well as proteins with different
molecular size, including the inflammatory peptide tumor necrosis
factor alpha (TNFa). In seven uninfected CAPD patients samples of
peritoneal dialysis effluent (PDE) were obtained after 0, 2, 4 and 8 hours
dwell time for analysis of urea, creatinine, electrolytes, total protein,
albumin, /32-microglobulin (2m) and TNFa. TNFa and f2m were
determined by specific enzyme immunoassays. A time dependent
increase in peritoneal dialysate concentrations of all parameters was
observed. However, TNFa in peritoneal effluent showed rather high
concentrations at the beginning of the CAPD cycle, the levels dropped
after 2 hours, followed by an increase after 4 and 8 hours of dwell-time
with a kinetics similar to that of the other proteins. Despite the initial
high TNFa concentrations, it is suggested that TNFx appears in the
peritoneal cavity by route of transperitoneal protein transport rather
than by local, intraperitoneal production.
Effect of suramin on transport systems of weak organic acids and bases
in rat renal cortical slices and on lipid peroxidation in renal cortical slices
and microsomes. J. Hannemann, K. Baumann, Department of Cell
Physiology, Institute of Physiology, University of Hamburg, Hamburg,
Germany. Suramin is widely used as a trypanocidal agent. Recently, it
has been applied as an anticancer drug and against AIDS. One of the
major side effects is nephrotoxicity. Suramin was evaluated for its effect
on uptake of weak organic acids (PAH) and bases (TEA) in renal
cortical slices, prepared from male Wistar rats. Furthermore, the
peroxidative potential of suramin in slices and rat renal microsomes was
estimated (production of malondialdehyde, MDA). Slices were incu-
bated in phosphate buffer medium, containing suramin (0.1—10 mg!ml).
Microsomes were incubated in Tris HCL buffer medium, containing
suramin (4 mg/mI) and pro-oxidants (ascorbic acid andlor Fe2). The
simultaneous incubation of suramin and PAH, as well as the successive
incubation (1. suramin, 2. PAH) reduced PAH-uptake in renal cortical
slices at all suramin concentrations tested. In both incubation systems
uptake of TEA was only reduced by the highest suramin concentration
investigated. MDA-content of the incubation medium of renal cortical
slices increased time- and concentration-dependently after incubation
in suramin, reaching values twice as high as control medium values.
Under the condition of stimulation by pro-oxidants, the suramin-
induced MDA production was highest, compared to corresponding
controls, with stimulation by ascorbic acid. The results suggest that
suramin interacts specifically with the transport system for weak
organic acids (PAH). Lipidperoxidation may contribute to suramin-
induced nephrotoxicity.
Blood pressure, metabolic control and decrease of kidney function in
proteinuric diabetics 1980—1989. U. Gruenwaldt, C. Hasslacher, C.
Manegold, P. Wahl, Medical University Clinic Heidelberg, Heidelberg,
Germany. Hypertension and metabolic control which influence progres-
sion of nephropathy, are difficult to adjust as shown in studies with
proteinuric Type I diabetics. No data are available for Type II diabetics
as yet. Since treatment modalities have been improving last years we
analyzed quality of metabolic control (HBA1), blood pressure (BP)
treatment (median systolic and diastolic BP), and the decrease of
kidney function (calculated creatinine clearances) in diabetics with
onset of proteinuria between 1980—1989. Diabetics without proteinuria
(matched for sex, age, and duration of diabetes) served as controls.
Median HBAI and diast. BP were equal in proteinuric Type I diabetics(N = 17) and controls. Although syst. BP was higher in proteinuric
patients (137 vs. 127 mm Hg), decrease of kidney function was similar
in both groups (1.1 vs. 0.8 ml!min!year). In Type II diabetics with
proteinuria (N = 18), median HBA1, syst., and diast. BP were higher
and decrease of kidney function was faster than in controls (3.8 vs. 1.3
mI/mm/year). These findings demonstrate that improved metabolic and
BP control could stop progression of nephropathy in Type I diabetics.
However, similar good results could not be achieved in proteinuric
Type II diabetics as yet.
Is a triple therapy including cyclosporin A (CsA) after kidney trans.
plantation less nephrotoxic than other therapeutic regimen? P. Heering,
B. Grabensee, Nephrology Department, Dusseldorf, Germany. Long
term prognosis of kidney transplantation (tpx) is impaired by cyclo-
sporin A (CsA) induced nephrotoxicity. Reduction of CsA by using a
triple therapy has been proposed to be less nephrotoxic. We performed
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renal function studies in patients (pts) with stable renal function
(creatinine 2.0 mg/dl) to investigate whether patients after tpx using
triple therapy maintain a better graft function. Three groups of pts were
studied: (1.) 35 pts treated with CsA and methyiprednisolone (mp); (2.)
20 pts treated with CsA, azathioprine (Aza) and mp; (3.) 15 pts treated
with Aza and mp. Parameters investigated were: C1,, CPAH, sodium
sulfate and bicarbonate loading. Plasma renin activity (PRA) and
aldosterone (Al) were measured basally and after stimulation with 40
mg furosemide iv. Results: CsA trough levels in the monoclonal assay
were decreased in group 2 (103 9.6 nglml) as compared to group 1
(136.5 8.6 ng/ml), C (mllmin/1.73 m2) and CPAH (ml/min/1.73 m2)
were significantly impaired in pts receiving CsA. Group 1: C1, 76.1
3.9; CPAH: 264 15.9; group 2: C1,,: 69.8 2.8; CPAH: 268.8 11.8;
group 3: C1,,: 89.6 4.8; CPAH: 338.7 4.5. Incomplete distal tubular
acidosis could be demonstrated during administration of CsA in 8 pts
from group 2 and 3 from group 3 but none of group 1. Hyporeninemic
hypoaldosteronism could be demonstrated in 4 pts of group 1 and I pt
from group 2 during the administration of CsA. Dose reduction of CsA
does not prevent CsA induced nephrotoxicity. CsA induced nephrotox-
icity can be proven in the distal tubular segment.
Increase of thromboxane B2 and 6-oxo-PGF1, during administration of
CsA. P. Heering, H. Strobach, K. Schror, B. Grabensee, Departments
of Nephrology and Pharmacology, Düsseldorf, Germany. The aim of
the study was to determine the influence of cyclosporin A (CsA) on
prostacyclin and thromboxane (Tx) generation. Four groups of patients
were studied. Group 1: Controls, N = 10. Group 2: Patients without
kidney disease treated with CsA, N = 10. Group 3: Patients after
transplantation treated with azathioprine, N = 10. Group 4: Renal
transplant recipients receiving CsA, N = 10. Parameters investigated:
C1,,, CPAH, TxB2 in plasma, serum and urine; 6-oxo-PGF1,, in plasma
and urine, urinary 2,3-dinor-TxB2 excretion. Results: CRAN and C1,,
were significantly decreased during CsA treatment. Plasma TxB2 levels
were enhanced in patients without kidney disease receiving CsA (group
2) amounting to 189 106 pg/mI as compared to 12 4 pg/mI in controls
(group 1). In patients without kidney disease (group 2), plasma 6-oxo-
PGF1,,, was increased (20 9 pg/ml) as compared to controls in group 1.
Plasma TxB2 and plasma 6-oxo-PGF1,, were increased in renal graft
recipients without any difference due to different immunosuppressive
drugs. Treatment with CsA was associated with impaired renal function
and resulted, in patients with kidney disease, in elevated plasma TxB2
and plasma 6-oxo-PGF1,,,, This effect could not be proven in renal graft
recipients. Conclusions: We suggest that the deleterious effect of CsA
on kidney function is presumably not paralleled by corresponding
changes in prostaglandin and Tx formation.
Normoglycemic hyperglucosuria in renal failure, a diagnostic sign of
renal byperperfusion. V.H. Heimsoth. Department of Internal Medi-
cine, Ostseeklinik Damp and Dialysis, Department in Damp, Germany.
The normoglycemic extra glucose excretion in patients with renal
failure is a criterion indicating hyperperfusion of the kidneys. After
ruling out diabetes mellitus and renal diabetes, this hyperglucosuria can
be demonstrated as a rule in the various known renal hyperperfusion
syndromes like the renal failure on which this study is based, but also
in nephrotic syndrome, pregnancy kidney, etc. It is easy to measure the
hyperglucosuria using the hexokinase method, and it can be readily
discriminated from the basal glucosuria of patients with kidney diseases
(GFR of more than 30 ml) and healthy subjects, which vary within a
narrow range.
Color-coded duplex sonography for early detection of renal allograft
rejection. M. Hollenbeck, M. Stuhrmann, R. Trapp, G. Fürst, B.
Grabensee, Department of Nephrology, Heinrich-Heine Universitdt,
Düsseldorf, Germany. In postischemic acute renal failure (piARF)
possibilities to examine the graft function are limited. With color-coded
duplex sonography assessment of the renal arterial blood flow nonin-
vasively and without radiation is possible. Like in renal transplant
rejection (REJ), diastolic blood flow is diminished resulting in a higher
Pulsatility Index (P1) as it is during piARF. It is not possible to
differentiate between piARF and REJ by a single P1-value. Therefore
we have serially analyzed (2—3 times/week) the arterial blood flow
pattern to find out whether REJ can be detected by means of the
dynamic course of P1. Furthermore, we studied if REJ can be detected
by color-coded duplex sonography prior to increments in serum creat-
mine. Methods: A total of 505 duplex sonographic examinations were
performed with 3.0 and/or 7.5 MHz transducers (Quantum, Philips
Medical Systems, Hamburg, FRG) in 45 patients at intervals of 2 to 6
days. During each examination 2 to 4 intraparenchymal arterial blood
flow patterns were analyzed. Results: 44 rejection episodes occurred
(25 biopsy-proven). During piARF 23/26 REJ showed an increase in P1
before diagnosis of REJ (P1 increased 32.9 56,8% per day 2.0 2.6
days before diagnosis of REJ) (mean SD). Without piARF 15/18 REJ
showed an increase in P1 before the histological or clinical diagnosis of
REJ (P1 increase 16.3 29.8% per day; 3.8 5.5 days before diagnosis
of REJ). Conclusion: With frequent color-coded duplex sonography
examinations of intraparenchymal arterial blood flow, it is possible to
detect REJ during piARF as well as in grafts with excretory function. In
the majority of cases the increase in P1 occurred earlier than serum
creatinine rose and/or histological diagnosis of REJ was made. The
dynamic course during anti-rejection treatment is of prognostic value.
The sensitivity of detecting REJ seems to be impaired in repeated REJ.
In these cases we sometimes saw the increase in P1 some days after the
histological or clinical diagnosis of REJ.
Hemolytic-uremic syndrome and thrombotic-thrombocytopenic pur-
pura (HUS/TTP) in adults. M. Hollenbeck, U. Zawischa, J. Passlick-
Deetjen, C. Au!, F. Kemmer, B. Grabensee, Department of Nephrology,
Heinrich-Heine Universitdt, Düsseldorf, Germany. Hemolytic-uremic
syndrome and thrombotic-thrombocytopenic purpura (HUS/TTP) is a
rare disease and probably is an entity with different clinical expressions
of one disease. The etiology is unknown. There are mostly case reports
concerning the etiology, clinical course, histological findings, treatment
and prognosis. We want to report 27 adult patients (16 female, 11 male)
with HUS/TTP. Results: All patients had thrombocytopenia 37000
32700/jl (mean SD), Coombs-negative hemolytic anemia (Hb 89 22
gil; LDH 1905 1280 U/I) and severely fragmented red blood cells in
the peripheral blood smear. Renal function was impaired in 25/27 with
a serum creatinine of 5.9 3.7 mg/dl. Twenty of 21 had histological
findings in kidney biopsy characteristic of HUS/TFP. Prior to HUS/
'VFP 9/27 have had gastrointestinal infections, 8/27 had systemic vas-
culitis, 4/27 received cyclosporin A after organ transplantation and 4/16
women were taking oral contraceptives. We saw no evidence that
prognosis was associated with platelet count, LDH and Hb on admis-
sion or with age and sex. Blood pressure and serum creatinine on
admission as well as treatment with plasmapheresis were of importance
concerning the outcome of renal function. Plasmapheresis was done in
13 patients 8 times (4—14) replacing 13 units of fresh-frozen plasma each
time, respectively. With plasmapheresis 1/13 patients died after the
second session, 2/13 had end-stage renal failure and 10/13 had a good
renal function at discharge (creatinine 1.36 0.19 mg/dl). Without
plasmapheresis 2/14 patients died, 9/14 had end-stage renal failure and
3/14 had an impaired renal function (creatinine 2.80 + 1.78 mg/dl) at
discharge. Conclusion: In our patients plasmapheresis highly improved
prognosis regarding kidney function, while survival was not affected.
Therefore we support early and frequent plasmapheresis with fresh-
frozen plasma in adult HUS/TTP independent of the underlying disease.
Influence of converting enzyme inhibition and renin inhibition on renal
hemodynamics in the conscious marmoset. U. Humke, J.M. Wood, K.G.
Hofbauer, M. Ziegler, Department for Urology, University Hospital,
Homburg/Saar, Germany, and Cardiovascular Research Department,
Ciba-Geigy AG, Base!, Switzerland. To investigate whether the renal
effects of a converting enzyme inhibitor (CEI) are entirely due to the
blockade of angiotensin H formation, clearance measurements were
performed in conscious marmosets (Callithrix jacchus) after single or
sequential administration of a renin inhibitor (RI) and a CEI. Para-
aminohippurate and inulin were used to measure renal plasma flow
(RPF) and glomerular filtration rate (GFR) during 6 urine collection
periods of 20 mm. After 2 control periods one of the following
substances was administered i.v.: 0.9% saline (1 ml/kg), the CEI
enalaprilat (2 mg/kg), the renin-inhibitory monoclonal antibody, R-3-
36-16 (0.1 mg/kg), alone or followed by enalaprilat (2 mg/kg) after 40
minutes (N = 8 per group). CEI and RI lowered blood pressure to a
similar extent when administered alone (baseline BP: 102 1 mm Hg;
delta BP: —16 4 and —13 4%, respectively). The CEI did not induce
a further decrease in BP when administered after RI. RPF (2.4 0.2
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mllmin/100 g body wt) increased after CEI, RI and CEL + RI by 33
9, 40 6 and 38 9%, respectively. In control and treated groups GFR
(0.48 0.06 ml/minIlOO g body wt) remained unchanged while filtration
fraction fell by about 20%. In conclusion, the results show that RI and
CEI have comparable effects on BP renal hemodynamics, which for the
CEI in normotensjve marmosets can be entirely attributed to the
blockade of angiotensin II formation.
Endurance capacity of dialysis patients with renal anemia under
erythropoietin (EPO) administration. H. Jedicke, H. Lange, Center of
Internal Medicine, Department of Nephrology, University of Marburg,
Marburg, Germany. The physical performance in dialysis patients
improves after correction of anemia due to EPO administration. The
most appropriate level of hemoglobin after EPO is still unknown.
Endurance performance was tested in patients on R.D.T. before the
start of the EPO administration (measurement Ml), during the increase
of hemoglobin (M2) and at the beginning of the preserving therapy (M3).
In 16 patients (3 f, 13 m, age 52 17 years) the endurance capacity
(anaerobic threshold) was tested at a treadmill with a constant workload
of 0.7 W/kg body wt during 6 minutes. From a heart rate, blood
pressure, breathing volume, V02, VCO2 and the dependent parameters
respiratory quotient and ventilatory equivalent, the anaerobic threshold
and endurance capacity were calculated. Moreover, 11 healthy volun-
teers with Hb 14.6 1.1 g/dl (K) served as controls. Before EPO (Ml,
Hb = 7.5 0.9 g/dl) 8 of 14 patients worked above their anaerobic
threshold. At M2 (Hb = 10.0 0.6 gldl) only 6 of 16 patients, and at M3
(I-lb = 11.7 0.7 g/dl) just 3 of 14 patients, remained working above
their anaerobic threshold. Hence, endurance capacity improved in
parallel to the increment of hemoglobin from 7.5 to 10.0 g/dl and also
from 10.0 to 11.7 g/dl. Correspondingly, a continuous decrease of heart
rate (in the minute of exercise) was observed from 122 16/mm
(Ml) to 111 15/mm (M2) and to 100 16/mm. (M3) under the same
load of 0.7 W/kg body wt and steady state conditions, respectively. All
subjects of the control group (K) exercised at 0.7 W/kg body wt below
their anaerobic threshold. In patients on R.D.T. between Hb = 7.5 and
11.7 g/dl a limit, whereabove no further improvement of endurance
performance appeared, was not observed. Therefore, the appropriate
EPO therapy should be fixed individually, considering its side effects,
some of which seem to be Hb dependent.
Oxygen capacity and effectiveness of energy turnover under EPO
therapy. H. Jedicke, H. Lange, Center of Internal Medicine, Depart-
ment of Nephrology, University of Marburg, Marburg, Germany. EPO
administration improves anemia and exercise capacity of patients with
ESRD. It is still unknown, however, whether the improvement of
exercise capacity is due to the increased oxygen capacity alone or
influenced additionally by an improved nutritional state and training. If
it was due only to the increased oxygen capacity, the effectiveness of
energy turnoveer should remain unchanged. To test the effectiveness,
the oxygen consumption and energy turnover were determined under
steady state with a constant work load at different levels of oxygen
capacity. The effectiveness is given as percentage of mechanical
workload on total energy turnover. Twelve patients maintained on
R.D.T. (3 f, 9 m, age 48 18 years) were subjected to endurance
performance 3 times: (1.) before EPO administration at Hb = 7.4 0.9
g/dl, (2.) during the increase in hemoglobin at Hb = 10.0 0.6 g/dl and
when the aim hemoglobin was reached, at Hb = 11.6 0.7 g/dI.
Moreover, 11 healthy volunteers (2 f, 9 m, age 44 14 years) with Hb
= 14.6 1.1 g/dl (K) served as controls. All measurements of
endurance capacity and effectiveness were realized at a treadmill in
sitting position with the same workload of 0.7 W/kg body wt over 6
minutes and with a constant moving frequency. There was no physical
training in the meantime. The effectiveness was 14.5 2.0% before
EPO administration at Hb = 7.4 g/dl, 16.2 1.9% during the increase
in hemoglobin at Hb = 10.0 g/dI and 16.4 1.3% at the aim hemoglobin
of 11.6 g/dl. In all 12 patients an improvement of endurance perfor-
mance and of maximum capacity was obtained. In healthy subjects the
effectiveness was 16.6 1.0% at Hb = 14.6 g/dl. The results show an
increased degree of effectiveness when Hb increased from 7.4 to 10.0
gJdl. When Hb raised to 11.6 g/dl, no further improvement of effective-
ness was observed. Already at Hb = 10.0 g/dl the effectiveness nearly
reached the level of healthy untrained subjects with a normal Hb of 14.6
g/dl. Hence, the exercise improvement after EPO below Hb 10.0 g/dl
appears to be caused not only by elevated oxygen capacity but also by
an improved effectiveness.
Effects of hemorrhage and exchange transfusion on plasma erythropoi-
etin concentrations (EPO) in conscious dogs. A. Just, H. Ehmke, P.
Persson, K. U. Eckhardt, A. Kurtz, H. Kirchheim, I. Physiolgy Insti-
tute, University of Heidelberg, and Physiology Institute, University of
Zurich, Zurich, Switzerland. The effects on circulating EPO levels of an
acute blood loss were studied to investigate the hypothesis that there
may exist factors which influence EPO production independently of
changes in kidney oxygen supply. For this purpose, conscious dogs
were subjected to nonhypotensive hemorrhage (14 mllkg in 10 mm),
exchange transfusion (30 mI/kg) and control experiments without any
intervention. Mean aortic pressure (MAP), heart rate (BR), central
venous pressure (CVP), hematocrit (HCT), renal blood flow (RBF),
arterial and renal venous partial-pressure of oxygen (paO2 and PO2)
and plasma EPO (by RIA) were measured before and for 4½ hr after the
respective intervention. Blood was reinfused after the first 3 hr. (1.)
After hemorrhage (N = 7) MAP initially fell by 14 3 mm Hg but did
not significantly differ from the control level (105 3 mm Hg) 1 V2 hr
later. CVP was reduced immediately by 3.9 0.8 cm H20, remaining at
this level until the blood was reinfused. Neither Pa°2 nor RBF showed
any changes, while HKT slightly decreased from 35 2% to 33 2%,
With an onset after 2 hr, plasma EPO increased to 144 21% of control
at 3 hr after hemorrhage and to 151 15% at the end of the experiment
(4½ hr). (2.) Exchange transfusion (N 5) reduced HCT from 30 3%
to 18 4%, while CVP decreased slowly. No reductions were found in
P°2 or RBF. EPO levels, showing a similar time course as compared
with hemorrhage, increased to 153 16% and 237 22%, respectively.
(3.) Under control conditions (N = 3), no changes were found except
for a slight decrease of CVP. Unexpectedly plasma EPO began to rise
after 160 to 170 mm, reaching 122 6% (3 hr) and 122 10% (4½ hr).
24 hr after each experimental intervention all values had returned to
control levels, except for a lowered HCT after exchange transfusion.
While the increase in EPO concentration after exchange transfusion can
be easily explained by the rapid reduction of the HCT, several factors
may contribute to the stimulation after hemorrhage (small reduction of
the HCT, fall in CVP). The 2 hr delay of the rise of plasma EPO after
exchange transfusion and hemorrhage corresponds very well to its
cellular regulation, which probably occurs at the level of transcription.
Proteolytic degradation of isolated diabetic basement membrane can be
normalized by in vivo treatment with aminoguanidine. H.P. Kempe, C.
Hasslacher, K. Geisen, K. Engelmann, Heidelberg/Frankfurt, Ger-
many. Non-enzymatic glycation of capillary basement membrane (BM)
proteins and formation of advanced glycation end-products (AGE)
leads to increased cross linking on long living proteins like collagen.
This in turn results in alterations of physical and biochemical properties
of the BM filter. The formation of AGE can be inhibited by aminoguani-
dine (AG). We investigated the effect of AG on proteolytic degradation
of BM in diabetic rats, which received AG in drinking water (1 g/liter)
during a period of 12 weeks. Untreated diabetic and non-diabetic
animals served as controls. AG had no effect on blood glucose or body
weight in diabetic rats. After treatment period, glomerular BM was
isolated and incubated for 18 hr in Tris-HCI buffer containing cathepsmn-
B I. After centrifugation, the supernatant, which contained degraded
proteins, was analyzed by means of SDS-PAG Electrophoresis and
densitometry. Compared with non-diab. controls, supernatant of the
cathepsin-B 1-digested BM of untreated diab. rats contained signifi-
cantly more peptides with molecular weights (MW) over 30 kD. The
concentration of peptides with MW below 30 kD was significantly
lower. BM of AG-treated rats showed, after enzymatic degradation, the
same pattern of peptides as non-diab. controls. These results indicate
that AGE of BM proteins cause an alteration of proteolytic degradation,
which can be prevented by AG.
The influence of continuous hemofiltration (CII) on the elimination of
protein split products and the proteolytic serum activity in acute renal
failure (ARF). H. Kierdorf, H. Melzer, J. Reihl, B. Heintz, TA. Bock,
H.G. Sieberth, lind Medical Clinic, RWTH Auchen, Germany. The
postaggression syndrome in ARF is known to cause lethal complica-
tions due to protein catabolism. A positive correlation of the nitrogen
loss by catabolism, proteinase activity and the concentration of protein
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split products is described. The effect of CH on the elimination of
protein split products and on the proteolytic serum activity was
investigated. Total nitrogen excretion (micro-Kjeldahl), proteolytic
serum activity (Azocasein), the plasma concentration and the excretion
of protein split products (Lowry) were measured in 32 patients with
ARF and at least one additional organ failure in whom CH had to be
performed. (veno-venous, pump-assisted). Results:
N Range x S
Nitrogen excretion Pat. 32 14.8-42.8 22.9 7.4
g/day Vol. 15 9.2—14 11.5 1,3
Proteolytic activity Pat. 32 0.4—48.5 3.5 8.3
serum U/liter Vol. 15 0.0—0.3 0.1 0.1
Protein split products Pat. 32 40—359 159 92
plasma mg/liter Vol. 15 10—48 27 10
Protein split products
excretion g/day Pat. 32 0.9—17.3 4.8 3.5
Compared to healthy volunteers total nitrogen excretion, proteolytic
activity and protein split products were significantly higher in all
patients. The protein split products were effectively filtered by CH
(sieving coefficient 0.8). Despite a daily excretion of up to 17 g, neither
the corresponding plasma concentrations nor the proteolytic activity in
serum nor protein catabolism changed. In conclusion, protein split
products which are increased due to a high proteolytic serum activity
are effectively eliminated by continuous hemofiltration. However, this
does not improve the catabolic state, which may be explained by the
continuing increased proteases activity.
Epidemiology of type I and type II diabetes at the beginning of
hemodialysis therapy: A prospective trial. M. Koch, W. TschOpe, W.
Kösters, E. Ritz, Departments ofNephrology, Universities of Düssel-
dorf, Heidelberg and Mannheim, Germany. There are different reports
about the relative risk of end-stage renal disease in type I and type II
diabetics. In a multicenter study (28 dialysis units in FRG) we examined
208 diabetic patients reaching ESRD. The diabetes classification was
done according the criteria of the National Diabetes Data Group (1).
Results: The mean age of all diabetics was 60 years with a range from
22 —82 years. Diabetic women had a mean age of 64 years (range 22—82
years), diabetic men had a mean age of 55 years (range 27—78 years).
Seventy-one patients (34%) were type I, 128 patients (62%) were type II
diabetics, 9 patients (4%) have had a Mody. The mean age of type I
diabetics was 49 years (range 22—76), of type II diabetics 65 years (range
37—82). A total of 65% of type I diabetics were men, 35% were women,
and 40% of type II diabetics were men, 60% were women. Whereas the
type I diabetics had a medical history of 22 years before reaching
ESRD, it could be shown that type II diabetics had reached ESRD after
12 years of diabetes (mean values). Conclusions: Regarding the data
from the European Dialysis and Transplant Association (EDTA) (2) we
would expect a relation of type I/type II to be 70/30. In fact we found a
relation of 34/62. This relation seems to be more realistic concerning the
data of diabetes type I and type II in the general population. In the
general population Skrabalo et al (3) found a relation of 20/80. Our
results suggest that the risk of renal failure in type II diabetes is higher
than expected in the past. Literature: 1. National Diabetes Data Group:
Classification and Diagnosis of Diabetes Mellitus and other Categories
of glucose intolerance. Diabetes 28:1039, 1979 2. Brunner RP et a!:
Renal replacement Therapy in Patients with Diabetic Nephropathy
1980—1986. Report from European Dialysis and Transplant Association
Registry. Nephrol Dial Trans 3:585, 1988 3. Skrabalo et al: Epidemiol-
ogy of Diabetes. Verh Dtsch Ges Inn Med 92:532, 1986
Cardiovascular events in diabetics at the beginning of hemodialysis
therapy: A prospective trial. M. Koch, W. Tschdpe, W. KOsters, E. Ritz,
Departments of Nephrology, Universities of Düsseldorf, Heidelberg
and Mannheim, Germany. Nothing is known about the frequency of
cardiovascular disease and/or the relating risk factors in diabetics
reaching end-stage renal disease. In a prospective study carried out
between 1985—1987 208 diabetics were studied. Diabetes classification
was done following the criteria of the National Diabetes Data Group.
Thirty-four percent (71) of the patients had type 1,62% (128) type II and
4% (9) type MODY diabetes. One or more cardiovascular events were
reported by 106 patients. A history of angina pectoris was given by 32%
of type I and 48% of type II diabetics. Seven percent of type I and 23%
of type II started dialysis with a prior history of myocardial infarktion.
TIA was reported in a frequency of 21% in type I and 28% in type II. A
definitive event of stroke was claimed by 8% of type I and 17% of type
II. Amputation had been done in 10% of type I and 13% of type II.
Plasma cholesterol was significantly related to myocardial infarction,
but not to peripheral arterial disease or stroke. The frequency of
amputation was significantly higher in smokers (active and non-active)
than in non-smokers. The data suggest that known risk factors of the
non-diabetic population are also clearly operative in diabetics with renal
insufficiency. They show the addition of artriosclerotic age-dependent
events to specific diabetic disease, which leads to a substantial increase
of further cardiovascular risk, especially in type II diabetics.
Lipid abnormalities in dialyzed diabetic patients: A comparison be-
tween diabetics and non-diabetics. M. Koch, W. Tschope, E. Ritz, B.
Grabensee, Departments of Nephrology, Universities of Düsseldorf
and Heidelberg, Germany. Little is known about the effect of patho-
logical lipid concentration on dialyzed diabetic patients. In a prospec-
tive study evaluating the cardiovascular risk profile in chronic dialyzed
diabetic patients, we measured triglyceride, cholesterol, Id!, hdl, apo-
lipoprotein a and b in 158 diabetic and in 71 non-diabetic dialyzed
patients at the beginning of hemodialysis therapy. The patients were
matched in age, sex and body weight, Results: Diabetics versus
controls (51 type I and 101 type II) had higher cholesterol (231 mg/dl vs.
210 mg/dl), higher ldl (163 mg/dl vs. 137 mg/dl), and lower hdl (32 mg/dl
vs. 41 mg/dl). Diabetic men in particular had a significant higher ldl than
the control group (type 1168 mg/dl, type 11159 mg/dl vs. controls 125
mg/dl). In diabetic men and women the hdl level was significant lower
than in controls (women type I 33 mg/dl, women type II 33 mg/dl vs.
controls 42 mg/dl; men type I 36 mg/dl, men type II 26 mg/dl vs. controls
40 mg/dl). In the control group women showed a higher level for
cholesterol, IdI, triglyceride than men, These differences could not be
shown for hdl. Conclusions: (1.) Diabetics versus controls had signifi-
cant higher levels for cholesterol, ldl, triglyceride and significant lower
level for hdl. (2.) Non-diabetic women had higher levels for cholesterol,
Id!, and triglyceride than non-diabetic men. (3.) Significant differences
for cholesterol, ldl, hdl and triglyceride were found between diabetic
men and men controls. (4.) There were no significant differences
between diabetic women and nondiabetic women. (5.) Regarding the
various diabetic subpopulations, it was the older diabetic man who had
the worst lipid constellation.
Genetic markers for autosomal dominant polycystic kidney disease. G.
Kraatz, A. Frenzel, P. Stohlmacher, J. Spengler, S. Wegener, H.
Schüler, B. Jager, Department of Internal Medicine, University of
Gre jfswald and Institute of Forensic Medicine, University of Rostock,
Germany. Twenty non-related patients suffering from autosomal dom-
inant polycystic kidney disease were HLA-A, -B, -C and -DR typified,
and the HLA frequencies were compared with a normal population.
Tissue typing was performed with the Lymphocytotoxicity test using
180 well-characterized test sera. In contrast to the literature no signif-
icant differences were found. However, the value of erythrocytic
phosphoglycolate-phosphatase (PGP) phenotyping should be checked
in the genetic control and consultation, because the mutation for adult
polycystic kidney disease has previously been localized to the short arm
of chromosome 16 by the demonstration of genetic linkage with the
locus of phosphoglycolate-phosphatase (16 p 12 - 16 p ter). The family
trees showed a good correlation between PGP-phenotyping and the
ultrasonographic detection of adult polycystic kidney disease. Early
prediction of the diagnosis becomes possible.
Influence of 3-blockade on albumin excretion in healthy controls. BK.
Krümer, C.M. Erley, K.M. Ress, G.A. Muller, T. Risler, Section of
Nephrology and Hypertension, Department of Medicine, Tübingen,
Germany. The effects of /3-blockade with atenolol, bopindolol, and
propranolol (drugs known to have different effects on renal function) on
renal albumin excretion in 12 healthy, normotensive volunteers with
normal albumin excretion were examined. Despite a significant (P <
0.05) reduction of plasma renin activity during /3-blockade with each of
the employed /3-blocking drugs, a significant (P < 0.05) decrease of
systolic blood pressure and heart rate during treatment with atenolol
Abstracts 1307
and propranolol, no significant change of renal albumin excretion
(measured by means of an ELISA) in 24-hr collections of urine could be
demonstrated. Renal plasma flow (PAH clearance) was reduced during
treatment with atenolol and propranolol, and increased during treat-
ment with bopindolol (P < 0.05). Glomerular filtration rate (inuline
clearance) was reduced during treatment with propranolol and in-
creased during treatment with bopindolol (P < 0.05). Renal hemody-
namics are affected in different ways by the examined /3-blocking drugs
due to differences in intrinsic sympathomimetic activity and cardiose-
lectivity. Those differences have apparently no effect on renal albumin
excretion in normoalbuminuric volunteers. These studies are not useful
to predict the outcome of treatment with /3-blocking drugs in micro- or
macroalbuminuric patients.
Screening for microalbuminuria using frozen urine samples. B.K.
Kramer, 1. Lindena, G.M. Erley, T. Risler, Section of Nephrology and
Hypertension, Department of Medicine, Tubingen, Germany. A de-
crease of urinary albumin concentration dependent on the duration of
storage and possibly dependent on the pH of the urine sample and on
centrifugation before assay has recently been reported. Therefore 43
urine samples were investigated before and after storage at —20°C for 2
weeks and 3 months with special regard to effects of urinary pH and
centrifugation prior to assay. The urinary albumin concentration (mea-
surement by means of an ELISA) decreased significantly (P < 0.05)
after 3 months, but not after 2 weeks of storage at —20°C. Coating of
storage tubes with casein to prevent adsorption of albumin as well as
centrifugation of storage tubes prior to assay had no effect on the
decrease of urinary albumin concentration during storage. pH was
significantly (P < 0.02) lower in samples with a decrease of albumin
concentration (5.75 0.23) than in samples without a decrease of
albumin concentration (6.46 0.13). The number of samples with a
visible precipitation increased during storage at —20°C, reaching 44%
after 3 months. Urine samples with visible precipitation tended (P >
0.05) to have a lower pH, however, there was no apparent correlation
between presence of precipitates and decrease of albumin concentra-
tion. Storage of urine samples at —20°C for measurement of albumin
cannot be recommended for periods markedly exceeding 2 weeks. The
mechanism of the decrease in urinary albumin concentration remains
unclear (uric acid precipitates containing albumin7).
Endothelin's positive inotropic effect in rat cardiomyocytes: Role of
protein kinase C-dependent Na/H exchanger and of a pertussis toxin-
sensitive G protein. B.K. Kramer, T.W. Smith, R.A. Kelly, Section of
Nephrology and Hypertension, Department of Medicine, Tübingen,
Germany, and Harvard Medical School, Boston, Massachusetts, USA.
Endothelin, a vasoconstrictive peptide secreted from endothelial cells,
has been investigated with regard to its positive inotropic effects in
freshly isolated adult rat cardiomyocytes. The positive inotropic effect
was slow in onset (after 3—4 minutes), was long lasting, demonstrable at
100 fM and had its maximal effect at 1 flM, and the amplitude of
contraction was increasd by 70 to 100% (EC50 50 psi, N = 70). The
positive inotropic effect of 100 M endothelin was not due to an increase
of cytosolic calcium concentration (measurement with Fura-2), but
probably was due to sensitizing of myofilaments to calcium. The
positive inotropic effect of 100 M endothelin was in part due to an
increase of cytosolic pH (measurement with BCECF) of 0.08 (N = 12).
This endothelin-induced intracellular alkalosis was completely inhibited
by 100 tM amiloride and partially by the protein kinase C-inhibitors,
H-7 and sphingosine, and in addition by pertussis toxin. The positive
inotropic effect of endothelin was inhibited completely by pertussis
toxin and partially by inhibitors of protein kinase C and amiloride. The
present study demonstrates that endothelin exerts its positive inotropic
effect at low concentrations of the peptide mainly by sensitizing
myofilamets to calcium (in part due to intracellular alkalosis) and not by
increasing intracellular free calcium concentrations. Endothelin's ef-
fects are mediated via a pertussis toxin-sensitive G protein, the protein
kinase C, and the Na/H exchanger.
Influence of nephrotic syndrome on the incidence of thromboembolic
complications (TEC) in renal allograft patients. F. Kronenberg, K.
Lhotta, M. Spielberger, P. Kanig, Department of Clinical Nephrology,
Clinic of Internal Medicine, and Department of Transplant Surgery,
First University Surgical Clinic, Innsbruck, Austria. Medical literature
reveals 8% to 42% TEC in patients with nephrotic syndrome. Depend-
ing on the particular immunosuppressive therapy, these complications
also run very high (6% to 25%) following renal transplantation (RTX).
The aim of this study was to determine whether the occurrence of
nephrotic syndrome in renal allograft patients also increases the inci-
dence of TEC. Of 229 patients who underwent RTX between 1984 and
1989, 27 (11.8%) developed nephrotic syndrome; 17 cases were recur-
rent and eight de novo. Of 89 patients with primary glomerulonephritis,
16 (18%) developed nephrotic syndrome following RTX, nine of whom
were on cyclosporine-prednisolone, five on triple-drug scheme and one
each on azathioprine-prednisolone and cyclosporine alone. Nephrotic
syndrome was thus seen in 21.4% of patients on cyclosporine-pred-
nisolone and in only 13.2% on triple-drug therapy. The 17 recurrent
nephrotic syndromes were observed after a mean of 12.5 months. In
eleven (65%) of these patients graft rejection occurred 6.1 months after
onset of nephrotic syndrome. The eight de novo nephrotic syndromes
commenced after 26.8 months, with only two cases (25%) of organ
rejection. Four of 23 patients (17.4%) with nephrotic syndrome follow-
ing transplantation suffered five cases of TEC. Of 188 patients without
nephrotic syndrome, 40 (21.3%) showed a total of 47 TECs. Contrary to
expectation, nephrotic syndrome following RTX did not prove to be an
additional risk factor for TEC.
Relationship between bone turnover and plasma calcium efflux (CaEfl
in patients with uremic bone disease. P. Kurz, B. Bognar, T. Tsobanelis,
P. Roth, E. Werner, J. Vlachojannis, P. Grutzmacher, MC. Faugere,
H.H. Malluche, St. Markus Hospital, GSF Frankfurt, Germany, and
University of Kentucky, Lexington, Kentucky, USA. Hypercalcemia
may develop in uremic bone disease with high or low bone turnover.
The mechanism of the latter is not fully unravelled. To study the
relationship between bone turnover and CaEff, 12 patients with uremic
bone disease were evaluated by calcium (Ca) kinetic studies and bone
histomorphometry. 45Ca and 47Ca were given for determination of
intestinal Ca absorption and CaEff. CaEff reflects the rapid distribution
of the tracer within the exchangeable Ca pool which includes the plasma
Ca compartment. CaEff correlated positively with histological signs of
bone turnover including number of osteoblasts and osteoclasts, volume
of osteoid, peritrabecular fibrosis, mineral apposition rate, mineralizing
surface, bone formation rate and activation frequency (P < 0.01-0.001).
Intestinal Ca absorption did not differ between patients with low or high
CaEff values (44 vs. 46%). There was a positive correlation between Ca
absorption and 1,25 (OH)2 vitamin D (1,25D), PTH and l,25D. These
data indicate that low bone turnover is associated with low CaEff,
which could explain the tendency of patients with adynamic bone
disease or osteomalacia to develop hypercalcemia. Thus, clinical efforts
should not only be directed towards treating excessively high bone
turnover, but also towards avoiding low bone turnover in patients with
renal failure.
Improvement of calcium kinetics in the course of CAPD treatment. P.
Kurz, T. Tsobanelis, U. Ewald, P. Roth, E. Werner, J. Vlachojannis, P.
Griitzmacher, St. Markus Hospital and GSF, Frankfurt/Main, Ger-
many. A resistance of bone to the action of parathyroid hormone (PTH)
is found very early in the course of renal failure. Conflicting results have
been reported on the progression of renal osteodystrophy under CAPD
treatment. In the present study PTH effects on calcium kinetic param-
eters before and under CAPD treatment were to be determined. Fifteen
patients (pts) at the beginning of CAPD (group I) and 15 pts under
CAPD treatment (group 2) were studied by a double isotope technique
using two calcium (Ca) isotopes (45Ca and 47Ca). Intestinal Ca absorp-
tion (Abs), Ca retention (Ret) and Ca clearance (Cl) were determined
and correlated with biochemical data (iPTH, 1 ,25(OH)2 Vitamin D, Ca).
iPTH and Vitamin D concentration did not differ between the two
groups. Abs was similar in group 1 and group 2 (41 vs. 44%), but serum
Ca concentration was higher in group 2. Ret was slightly higher (27 vs.
31%), whereas Cl was significantly higher in group 2 (2.3 vs. 2.7; P <
0.05). In both groups these parameters were positively correlated with
iPTH levels. However, the slopes of the correlation curves between
iPTH and Ret or Cl were higher in group 2 (r = 0.5 vs. r = 0.7and r =
0.3 vs. r = 0.8, respectively), indicating a better response of these
parameters to iPTH under CAPD treatment. Ret and Cl are strongly
correlated with histomorphometric signs of bone turnover. Thus our
data indicate a better PTH response of the uremic bone under CAPD
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treatment, These data can explain the observation that osteomalacia
improves under CAPD treatment.
Validity of divided refill studies after acute ACE inhibition for identi-
fying unilateral renovascular hypertension (RVH). B, Kutkuhn, B. Gra-
bensee, Department of Nephrology, Heinrich-Heine-Universily, Düs-
seldorf, Germany. The reliability of divided renin studies after acute
ACE inhibition for identifying RVH remains controversial. Particular
uncertainties exit concerning the maintenance of antihypertensive
drugs and the power curves (renin ratio, renin secretion) suitable for
distinction between RVH and primary hypertension (PH). In 44 patients
with unilateral renal artery stenosis and postinterventional proven
RVH, and 58 patients with PH and unaffected renal arteries, we
determined sensitivity and specificity of divided renin studies after ACE
inhibition by means of discriminant analysis. Antihypertensive treat-
ment was not changed in these patients. The results of discriminant
analysis in terms of sensitivity and specificity of renin ratio and renin




Renin ratio before 23 96
Renin ratio after 25 mg 25 96
captopril
Renal vein secretion before 20 91
Renal vein secretion after 34 96
25 mg captopril
These results suggest, that both variables (renin ratio and secretion)
show an excellent specificity and poor sensitivity, which does not
improve after acute ACE inhibition. We conclude, that divided renin
studies even after acute ACE inhibition are of limited validity for
identifying unilateral RVH.
Liver-induced decrease of glomerular filtration rate. F. Lang, E.
Tschernko, E. Schulz,e, I. Ottl, D. Häussinger, Inst it utfur Physiologic,
University of Innsbruck, Osterreich, Medizinsche Klinik, University of
Freiburg, Deutschland. The pathogenesis of hepatorenal syndrome is
still not fully understood; a direct role of liver in the deterioration of
renal function is elusive. Since cell injury is usually paralleled by cell
swelling, the present study was designed to disclose a possible effect of
liver cell swelling on renal function. Liver cell swelling can be induced
by portal venous infusion of amino acids such as glutamine and serine
(but not glutamate), which are accumulated within the liver cells.
Catheters were placed into trachea, urinary bladder, femoral artery, a
jugular and an intestinal vein of anaesthetized Wistar rats (150 to 200 g
kg). After a control period glutamine (2 mol/min) was infused either
via a jugular or an intestinal vein. Intestinal venous glutamine lead
within minutes to a sustained but reversible decrease of GFR (by 51
6%, N = 7), urinary flow rate (by 41 7%), as well as urinary excretion
of sodium (by 32 9%) and potassium (by 64 13%). Jugular venous
glutamine did not elicit any of these effects. Transsection of the medulla
at the cervicothoracic junction abolished the effect of portal venous
glutamine. Portan venous serine (2 smol/min) but not glutamate mim-
icked the effect of glutamine. Portal venous infusion of glucagon (1
ng/min) alone or in combination with glutamine leads to an increase of
GFR (by 44 10% or by 34 4%, respectively). The experiments
disclose a mechanism of hepatorenal influence, possibly triggered by
liver cell swelling and requiring intact nerves. This mechanism could
participate in the generation of hepatorenal syndrome. Following oral
application of amino acids, the effect of amino acids on GFR is probably
reversed due to release of glucagon.
Maximal capacity in patients undergoing maintenance exercise—He-
modialysis following treatment with erythopoietin H. Lange, A. Voigi,
H. Jedicke, R. Meierhenrich. The reduced exercise capacity in patients
undergoing maintenance hemodialysis can be increased by a continuous
treatment with recombinant human erythropoeietin (rHuEPO). Maxi-
mum workload as well as circulation and respiration were investigated
by bicycle spiroergonletry. Twelve patients (3 f, 9 m; age 53.8 + 16.4
years; mean time on dialysis 51.1 + 54.6 months) performed exercise
testing before starting hemodialysis at certain haemoglobin levels: (A)
before treatment with rHuEPO, Hb 6.5—9.1 g/dl; (B) treatment with
rHuEPO, Hb 9.7—10.7 g/dl; (C) treatment with rHuEPO; Hb 11.0—12.8
gIdl; (D) at the same hemoglobin level as (C), at least 3 months later.
The initial workload at 20 watts was increased stepwise by 20 watts
every minute, and shortly before exhaustion by 10 watts. Heart rate,
breath frequency and ventilation volume/minute were registrated in
relation to the workload; the outcome of the maximum workload of
investigation (A) was put 100%. The results were compared to a control
group of healthy subjects (3 f, 9 m; age 45.1 + 10.8 years; Hb 14.5 + 1.0
g/dl). The maximum workload in (B) increased by 16.4 and in (C) by
23.7% and in (D) by 26.4% compared with (A). Heart rate decreased to
91.3% (B), 91% (C) and 92.2% (D). There was a decrement in breath
frequency and ventilation volume as well, Maximum relative workload
was 1.46 + 0.38 watt/kg in examination (D) compared to 2.85 + 0.91
watt/kg in the control group. This study shows a distinct increase of
maximum workload (especially A to B) as well as less demand to
circulation and respiration. However, workload could not be increased
to the level of healthy controls.
Expression of 1CAM-1 in renal allografts. K. Lhotta, R. Stauder, P.
Konig, Department of Internal Medicine, University Hospital of Inns-
bruck, Innsbruck, Austria. Intercellular adhesion molecule-I (ICAM-1)
is a glycoprotein of molecular wt 90,000, which is normally expressed
on macrophages, endothelial cells, activated T and B lymphocytes and
fibroblasts. Interaction of ICAM-1 with its ligand leucocyte function
associated antigen-l (LFA-1) is fundamental to many immunologic
reactions by stabilizing antigen independent adhesion. We investigated
expression of ICAM-1 in normal renal tissue and nine transplant
biopsies with the use of monoclonal antibody 7F7 and indirect immu-
noperoxidase staining. In the healthy kidney ICAM-l is found on
endothelial cells of glomerular and peritubular capillaries and other
vessels, in the mesangium, on the cells of Bowman's capsule and some
interstitial cells. In chronic cyclosporin A toxicity expression is un-
changed. In both acute and chronic sclerosing rejection, mononuclear
cells infiltrating the graft show intense staining. In the vicinity of
infiltrates expression on proximal tubular cells, mainly on the luminal
membrane, is observed. Staining of peritubular capillaries is enhanced.
Expression on mononuclear cells indicates their activation. Increased
expression on endothelial cells probably facilitates evasion of cells into
the tissue. ICAM-l on tubular cells, which is most likely induced by
locally produced cytokines, might render them more immunogenic and
vulnerable to cell-mediated lysis.
Hyperlipidemia and accumulation of remnants in CAPD patients:
Influence of beclobrate. I. Lubrich-Birkner, C. Wanner, 0. Summ, P.
Reetze-Bonorden, H.B. Steinhauer, W,H. Hörl, H. Wieland, P. Scholl-
meyer, Department of Medicine and Clinical Chemistry, University
Hospital of Freiburg, Freiburg, Germany. Continual losses of plasma
proteins into the peritoneal dialysate, reabsorption of remarkable
amounts of glucose from the dialysate and a decreased activity of
lipoprotein lipase are the main factors of hyperlipidemia and accelerate
atherosclerosis in CAPD patients. Therefore, we investigated the effect
of beclobrate, a new fibric acid derivative on lipid metabolism in 16
chronic renal failure patients (age: 26—65 years) treated by CAPD
(stable on CAPD and no peritonitis episode during the last 6 months) in
a 12 weeks trial. In association to pharmacokinetic data, obtained in
hernodialysis patients (Eur J Clin Pharmacol 36:A92, 1989) a normal
dosage of 100 mg beclobrate was chosen once daily. Cholesterol (Chol)
and triglycerides (TO) were determined by fully enzymatic methods.
The VLDL were isolated by ultracentrifugation in all patients. The
LDL concentration was determined by the difference between lipid
concentration in VLDL free serum and the HDL fraction after the
precipitation of LDL. Plasma levels of beclobrinic acid were monitored
in monthly intervals by HPLC. Beclobrate reduced serum cholesterol
by 19.3% (308.7 8.7 vs. 246.6 12.0 mg/dl), LDL cholesterol by
15.6% (199.9 10.2 vs. 161.9 10.3 mgldl), LDL-Apo B by 26.9%
(128.1 5.8vs. 91.6 5.0 mg/dl), triglycerides by 26.6% (258.9 36.7
vs. 178.4 22.4mg/dI), and VLDL-TG by 35.8% (179.4 37.7 vs. 97.8
18.8 mgldl) significantly. Apo Al increased by 17.1% (159 11,3 vs.
182.5 11.2 mg/dl), HDL-Chol by 18.7% (51.1 4.2 vs. 59.1 4.6
mg/dl). This increase is the consequence of the raising HDL3 (36.3
2.9 vs. 49.4 3.8 mg/dl), HDL2: 10.9 0.7 vs. 13.4 2.0 mg/dl). The
most important effect to the lipoprotein system was observed in the
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VLDL fraction: VLDL-Chol decreased by 40.1% (58.3 9.7 vs. 25.8
4.7 mg/dl), consequently TG/Chol-ratio increased high significantly
(3.26 0.19 vs. 4.22 0.29). The atherogenic index (LDL/HDL)
decreased significantly (4.33 0.4 vs. 3.01 0.35), too. Side effects
occurred in one patient at the end of the third month of treatment and
beclobrate was discontinued due to muscle pain (serum CPK 4190 U/I).
However, no accumulation of beclobrinic acid could be detected in the
plasma of all patients. These results demonstrate a remarkable decline
of serum cholesterol and triglycerides and a favorable correction of
dislipidemia under therapy with beclobrate in CAPD patients. Whether
the discrepancies between the data previously reported in hemodialysis
patients (no accumulation of beclobrinic acid and no clinical side
effects) and the present data (no accumulation of beclobrinic acid but
severe side effects, for example an increase of serum CPK and a
decreased function of peritoneal clearance) are due to a difference in the
clearance of non-protein bound beclobrinic acid or to an accumulation
of metabolites needs to be determined.
Micral-test——A new semiquantitative rapid test for detection of microal-
buminuria. C. Manegold, C. Hasslacher, P. Wahl, Medical University
Clinic, Heidelberg, Germany. Screening of microalbuminuria in dia-
betic patients is as yet the only possibility to detect diabetic nephrop-
athy in an early stage when therapeutic interventions are still beneficial.
For screening purposes there exist some rapid tests which qualitatively
discriminate between normal and elevated urinc albumin concentra-
tions. The Micral-Test is a specific, semiquantitative stick test for a five
level estimation of albumin concentration (0, 10, 20, 50, 100 mg/dl). It
combines chromatographic and immunological methods. In the present
study sensitivity and specificity as well as factors which may influence
test results were investigated. The albumin concentration of 160 dia-
betics measured by nephelometry as reference showed a good correla-
tion with the results of the Micral-Test. The sensitivity and specificity to
detect albumin concentration of more than 20 mg/liter was 86% and
97%, respectively. There was no influence on the results by storage in
plastic or glass vessels at 4°C for up to one week and by standing of
bacteriologically infected urines at room temperature for 24 hours. The
results show that the Micral-Test offers a sensitive and specific method
for semiquantitative estimation of microalbuminuria that seems insus-
ceptible to disturbances.
Detection of human cytomegalovirus DNA in renal tissue of patients
after bone marrow transplantation. J. Markovic-Lipkovski, C.A. Muller,
W. Kuhn, H. Einsele, G.A. Muller, Medical University Clinic, Depart-
ments II and III, Eberhard-Karls-University, Tubingen, Germany.
Viral infections are very frequent in patients after bone marrow
transplantation (BMT) but their diagnosis and differentiatial diagnosis
with GvH disease are still difficult. Renal tissue of 16 patients after
allogenic BMT (1 diagnostic biopsy and 15 autopsy samples) was
analyzed by the polymerase chain reaction (PCR) technique for the
presence of human cytomegalovirus (HCMV) and it was correlated with
immunohistological findings of mononuclear infiltrates and abnormal
expression of HLA-antigens. Seven out of 9 patients who died from
HCMV infections were shown to harbor HCMV in renal cells by PCR.
One out of 4 patients with only hepatic involvement of HCMV infection
was also found to carry HCMV-DNA in the kidney. In 1 further patient
suspected of suffering from renal GvH disease the kidney biopsy was
HCMV positive by PCR analysis. Kidney specimens of 3 patients
without HCMV infection of any other organ were negative for HCMV
by PCR. Immunohistological analysis in parallel revealed abnormal
expression of HLA-class II antigens on renal proximal tubular cells, as
well as moderately increased interstitial T cells in 6 HCMV positive
patients investigated. Thus the presence of HCMV in renal tissue is a
frequent finding in patients with extended and local HCMV infection
after BMT and a possible cause of immunohistological renal changes
present also in local GvH reaction.
Inhibition of compensatory renal growth by 1,25(OH)2D3 is it a direct
effect or indirect consequence of suppressed PTH secretion? S. Matthias,
R. Busch, J. Merke, G. Mall, E. Ritz, Department of Internal Medicine
and Pathology, University of Heidelberg, Germany. I ,25(OFI)2D3 has
antiproliferative actions in numerous cell systems. In renal cell carci-
noma lines 1 ,25(OH)2D3 dose dependently diminishes clonogenicity and
cell proliferation rate (Nakagura, Kidney mt 29:834, 1986). In a previ-
ous study we showed that low non-hypocalcemic doses of I ,25(OH)2D3
reduced renal compensatory growth after uninephrectomy (Kidney hit
35:384, 1989). Jobin (Kidney Irn 29:1124, 1986) found that PTH stimu-
lates renal compensatory growth. This prompted the present study in
which we examined whether the inhibitory effect of I ,25(OH)2D3 on
renal growth was direct, i.e. independent of PTH, or indirect, i.e. via
suppression of endogenous PTH. We examined the effect of 20 pmol
I ,25(OH)2D3/day s.c. (or solvent) 48 hours after uninephrectomy
(UNX) on the mitotic fraction in different renal structures of colchicin
pretreated (800 g Demicolcin for 8 hr) PTX rats substituted with 100
ng/kg/h4 1,34 bPTH (Bissendorf Company Wedemark) by osmotic
minipump (Aizet Company, model 2 ml 1). At the end of the experiment
SCa in 170 gPTX-UNX-PTH-animals with solvent was 1.14 0.38
mmollliter (±sD) and with 1,25(OH)2D3 1.5 0.25 mmol/liter. Mitoses
in renal cortex were 354 184 mm2 in solvent and 152 32 in
1 ,25(OH)2D3 treated animals. The respective figures for proximal tubule
were 286 160 vs. 122 34 and in distal tubule 68 31 vs. 30 6 (all
P < 0.05; N = 7 per group). The results document that 1 ,25(OH)2D3
reduces mitoses in kidneys after uninephrectomy even when endoge-
nous PTH secretion cannot be modulated.
How can the transition from normotensive (N) to borderline hyperten-
sive (RH) patients be determined? G.J. Meyer, V.E. Kollenbaum, D.
Will, K. Seidenstücker, A. Kohlhaas, H. Berbalk; I. Med. Universität-
Klinik, Abt. Nephrologie, Universität Kiel; Schiffahrtmedizinisches
Institut d. Marine, Psychologisches Inst itut III, Universiidt Hamburg,
Hamburg, Germany. Ergometric stress-testing procedures exist to
differentiate BH from N (Franz et al). Patients at risk to develop
hypertension are usually challenged less physically but more mentally
in everyday life, therefore it appears logical to look for a definition in
blood pressure behavior with mental stress-testing and compare these
results with ergometric findings. The blood pressure behavior of 46
volunteers (35 N, 11 BH) was studied with ergometric testing and
additionally over a 120 mm period with continuous blood pressure
recording during a mental stress situation. The blood pressure changes
during a standardized interview situation were selected as dependent
variable. A mental arithmetic test under noise exposure ("laboratory
stress situation") served as independent vairable in addition to the
blood pressure results of the ergometric recordings (with resting and
maximum blood pressure stimulation). In a multiple regression analysis
only the arithmetic test explained a substantial amount of variance (r =
0.86; P < 0.001). These results started the question, whether ergometric
blood pressure recordings are good predictors of blood pressure behav-
ior in everyday life, which are important to the development of
hypertension. In order to predict hypertension more precisely, mental
stress testing should be taken more into account than just ergometric
data alone.
Lysosomal damage after aluminum treatment. A. Muller, G. Stein, W.
Linji, V. Laske, H. Bräunlich, Ch. Fleck, K. Winnefeld, Departments of
Internal Medicine and Surgery, Institutes of Anatomy and Pharmacol-
ogy, University of Jena, Jena, Austria. The influence of repeated
aluminum (Al) administration (0.05 or 0.5 mg/lOO g body wt i.p. 5 times
weekly for 12 weeks) on the lysosomal enzymes N-acetyl-beta-D-
glucosaminidase (/3-NAG) and beta-glucuronidase (/3-Gluc) in the liver
and kidneys of adult female rats with intact kidneys (NR), or following
partial nephrectomy (5/6 NX) was investigated. After Al loading the Al
content of the liver increased 15- to 30-fold, that of the kidney 5- to
8-fold in comparison to control animals. At the high Al dose only the
free /3-NAG in the kidneys increased. Latent /3-NAG levels decreased
in both organs, the effect being dose related, reflecting a lysosomal
damage. Following Al loading with one exception, no elevation in total
enzyme activity was observed. The liver of both groups of animals
showed a decrease in free and total /3-Gluc activity after high Al loading
which may be explained by an inhibition of /3-Glue synthesis. The
results confirm that high doses of Al induce toxic effects and damage the
lysosomes in the liver and the kidneys. Repeated administration of Al
also interferes selectively with enzyme synthesis. The results indicate
that the extent of lysosomal damage correlates with dose and duration
of Al loading as well as the amount of stored Al with a possible toxic
tissue level of 3-5 mol/g dry substance. Electron microscopic exami-
nation of the homogenate supernatants confirmed the existence of intact
lysosomes. In the Al treated groups of rats the supernatants from the
1310 Abstracts
liver tissue showed only a few (mostly small) lysosomes. The lysosomes
in the supernatants from kidney tissue were smaller and their number
differed between groups.
Detection of human cytomegalovirus-DNS in renal biopsies with IgA
nephropathy. G.A. Muller, W. Kuhn, J. Markovic-Lipkoviski, K. Haist,
C. Boss, T. Risler, A. Bohle, C.A. Muller, Medical University Clinic,
Departments Ii and III, institute of Pathology, Eberhard-Karls-Uni-
versity, Tubingen, Germany. In the pathogenesis of different forms of
glomerulonephritis (GN) viruses play an important role. Human cyto-
megalovirus (HCMV) recently has been suspected to be involved in
inducing IgA nephropathy. The aim of this study was to detect
HCMV-DNA in renal tissue of patients with histologically-proven IgA
nephropathy by the polymerase chain reaction (PCR). Cryostat sections
of 10 renal biopsies with IgA nephropathy, of 7 biopsies with histolog-
ically-proven focal segmental glomerulosclerosis (FSGS) and of 9
normal cadaver kidneys offered for transplantation were used for DNA
extraction after proteinase K digestion. PCR amplification of a 147 bp
DNA fragment of the immediated early gene of HCMV with subsequent
slot-blot assay was performed. HCMV-DNA was detected by hybrid-
ization with digoxinene labelled probes. In all renal biopsies from
patients with IgA neophropathy HCMV-DNA was detected in a range
from 0.1 up to 1.0 fg. Three out of 9 donor kidneys were also positive
for HCMV-DNA. However, HCMV-DNA was not detected in any
renal tissue from patients with FSGS. These results reveal that HCMV-
DNA is present in kidneys with primary IgA nephropathy and thus may
play a major rolee in this disease. Analyses on larger numbers of renal
biopsies are currently being performed to extend and confirm these
results.
Atherogenic risk and proteinurla. G.A. Muller, H.O. Lueg, C. Erley,
M. Przechera, B.K. Kramer, T. Risler, Medical University Clinics,
Tubingen, Germany. Hyperlipidemia often occurs in patients with
glomerulonephritis (UN), especially in association with reduced renal
function or in chronic renal failure. To calculate the atherogenic risk
using the LDL/HDL ratio, a lipid electrophoresis was performed in sera
from 30 patients with different forms of GN prior to treatment. The
patients (age between 17 and 68 years) suffered from the following
diseases: 6 minimal change, 8 membranous nephropathy, 6 focal
segmental glomerulosclerosis, 10 mesangioproliferative GN. The pro-
teinuria ranged from 3.5—17 g/24 hrs, total plasma cholesterol concen-
trations from 217—677 mg/dl and plasma triglyceride concentrations
from 76—566 mg/dl, None of the patients was treated with drugs to
reduce hyperlipidemia prior to the analysis, The mean ratio of LDL/
HDL was between 1.4 and 33.4. The altitude of the LDL/HDL ratio
correlated strictly with the altitude of the proteinuria but not with the
level of plasma creatinine. Thus the treatment of proteinuria probably
influences the reduction of hyperlipidemia, and this is important for the
long-term prognosis of the underlying disease.
Immunohistochemical differentiation of cortical and papillary renal
fibroblasts. GA, Muller, J. Steinbach, L.G. Fine, J.T. Norman, A.
Knecht, H.P. Rodemann, Medical University Clinics, Tubingen, Ger-
many; Renal Division, Medical School, UCLA, Los Angeles, Calfor-
nia, USA; DevelopmentalBiology, Bielfeld, Germany. Renal interstitial
fibrosis (IF) influences the progression of renal diseases and is a major
cause for uremia. We showed that mitotic (MF) and postmitotic
fibroblasts (PMF) are involved in this process, and especially PMF are
responsible for an excessive high collagen synthesis and the production
of interstitial matrix proteins. For functional analysis cortical (CF) and
papillary (PF) fibroblasts from rabbits were isolated. A monoclonal
antibody, TN 46 (IgG2a) was raised against PF in culture of passage 2.
In cryostat sections of human and rabbit kidneys TN46 recognizes PF
and weakly also CF, and stains the mesangial region in addition. In
FACS analysis TN46 exclusively detected PF but not CF in culture of
passage 3, Furthermore, TN46 recognizes human renal but not skin
fibroblasts in culture. Thus TN46 does not only detect a cell surface
antigen but also a component of extracellular matrix, produced by PF in
culture.
Expression of intercellular adhesion molecule 1 (ICAM-1) on proximal
tubular epithelial cells in glomerulonephritis. G.A. Muller, J. Markovic-
Lipkovski, T. Risler, A. Bohle, CA. Muller, Medical University Clinic,
Departments II and III, institute of Pathology, Eberhard-Karis-Uni-
versity, Tubingen, Germany. The intercellular adhesion molecule 1
(ICAM-l) plays an important role for cellular interactions in the
immune response. The expression of ICAM-l on tubular epithelial cells
in 112 patients with different types of glomerulonephritis (UN) was as
follows: 12 rapidly progressive GN (RPGN), 11 membranoproliferative
GN (MPGN), 16 membranous UN (MGN), 14 focal segmental GN
(FSGN), 6 IgA-GN, 4 endocapillary GN, 34 mesangioproliferative UN(MesPGN), 9 minimal changes (MinCh) and 6 minor lesions, was
examined and compared to the expression of HLA-class II antigens.
Monoclonal antibodies: TU22 (HLA-DQ), TU34 (-DR), TU39 (-DiV
DP), FA (-DP) and for ICAM-1 were applied on cryostat sections by the
immunoperoxidase technique. Fifteen biopsies of normal kidneys of-
fered for transplantation were used as a control group. There was no
expression of ICAM-l on tubular cells in normal kidneys. However,
aberrant expression of ICAM-l was detected on proximal tubular cells
(PTCs) in ON mainly in association with interstitial cellular infiltrates:
10 RPGN, 10 FSGN, 12 MesPUN, 7 MPGN, 3 IgA-GN and 1 MinCh.
This abnormal expression of ICAM- 1 correlated in most cases with an
aberrant expression of HLA-DQ and -DP antigens on PTCs. Present
findings are further support of our previous hypothesis that PTCs may
participate in cellular-mediated immune reactions in different types of
UN. Further experiments with cultured PTCs may clarify the functional
importance of the abnormal expression of ICAM-l and HLA class II
antigens on PTCs.
Sequence of events leading to breakdown of podocyte structure in
hypertrophied glomeruli in rats. M. Nagata, W. Kriz, institute of
Anatomy and Cell Biology, University of Heidelberg, Heidelberg,
Germany. Glomerular hypertrophy is widely regarded as a crucial
forerunner of glomerulosclerosis, however, concrete linkage of both
has not been well understood. In experimental models of glomerular
hypertension or hypertrophy, glomerular epithelial cells (podocyte)
undergo characteristic structural alterations. We studied (by SEM and
TEM) the sequence of events leading to these abnormalities in hyper-
trophied glomeruli resulting from uninephrectomy in young rats. The
overall tuft hypertrophy includes the expansion of the peripheral
glomerular capillary loops toward the urinary space and leads to the
following early alterations. Podocytes apparently cannot keep up with
the overall tuft hypertrophy; their processes are exposed to increased
tension and are stretched Out. Primary processes become extremely
attenuated spanning large distances between remote capillaries. Fur-
thermore, the outer surface of glomerular capillaries are moved toward
the cell bodies of podocyte narrowing the subpodocyte space. Thereby
the flow resistance for the filtrate out of the subpodocyte space into a
common urinary space apparently increases followed by a rise in the
hydrauric pressure in the subpodocyte space. Chronically, the in-
creased subpodocyte pressure will bulge parts of the podocyte cell
bodies toward the urinary space causing the formation of large blebs
(pseudocysts). These pseudocysts increase in size and frequency with
time; as shown by previous studies, they appear to be decisively
involved in the development of glomerulosclerosis. In conclusion, the
exposure of podocytes to increased mechanical stress, to increased
tension as well as subpodocyte pressure causes the earliest structural
alterations in podocytes of hypertrophied glomeruli.
Effects of piretanide on renal function and the ANPIRAA system in
patients with the nephrotic syndrome. J. Plum, F. Plum, B. Grabensee,
Department of Nephrology, Heinrich Heine University of Düsseldorf,
Germany. Twelve nephrotic patients (34.6 18.1 years) with distinct
edema and a serum creatinine s 1.5 mg/dl were investigated without
diuretic medication and under the treatment with piretanide (P.) for 10
days. The dose was adapted in a run in period of 2 days so that a
decrease of body weight of at least 0.5 kg/day was achieved (27.3 21.9
mg P./day). Blood and 24-hr urine samples were taken on day 0, 1,4, 7
and 10, two hours after the morning intake. P. caused a significant
increase in urine volume (V0, +86%; P < 0.01) and in the clearance of
sodium (+62%; P < 0.05) and potassium (+55%; P < 0.05) in the first
24 hours of treatment. After 10 days of treatment V0 remained on a high
level (P < 0.05) while the clearance of sodium and potassium decreased
during treatment. Body weight diminished by 2.25 kg after 4 days and
by 2.33 kg after 10 days. The clearance of creatinine (102 51 mI/mm)
and the urinary excretion of protein (8.8 3.6 g/24 hr) remained
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unaffected during the whole study. Short and long term changes in
glomerular filtration rate (day 0: 100 25 mI/mm; day 10: 95 22
mi/mm) and effective renal plasma flow (day 0: 528 151 mI/mm; day
10: 498 123 ml/min) were not registered. Plasma renin activity showed
a significant increase with a maximum on day 7 of treatment (day 0:
median 2.6, range 0.7—30.0 ng/ml x hi; day 7: median 7.0, range
4.0—72.4 ng/ml x hr). Aldosterone reacted similar. ANP plasma levels
were elevated (day 0: 147 99 pg/mI) compared to healthy controls (62
27 pglml) and did not significantly change during P. treatment (day 10:
148 116 pg/mI). Piretanid proved to be an effective diuretic in treating
hyperhydration in the nephrotic syndrome. Under body fluid reduction
basic renal hemodynamic and clearance parameters were unchanged.
Plasma ANP levels remained elevated.
Prognosis of chronic glomerulonephritis with arterial hypertension. M.
Przechera, A. Weber, 1. Zäuner, P. Heering, G.A. Muller, B. Grab-
ensee, P. Schollmeyer, H. Franz, T. Risler, Departments of Internal
Medicine, Universities of Tubingen, Dusseldorf, Freiburg, UIm, Ger-
many. Patients with chronic glomerulonephritis (GN) often develop
arterial hypertension. To determine its prognostic significance 91 pa-
tients, 43 (46%) men and 48 (54%) women, with biopsy-proven GN (9
MPI, 16 FSGN, 27 MGN, 7 MPGN, 15 MESGN, 11 IGAN, 6 RPGN)
with or without nephrotic syndrome were observed over a mean period
of 43 23 months. The mean age was 36.9 years and ranged between
14 and 74 years. The patients were divided into two groups: 33 (36%)
normotensive patients (NT) and 58 (64%) patients with arterial hyper-
tension (HT) (>160/95) who remained normotensive under antihyper-
tensive treatment during the observation period. Serum creatinine
levels (normal < 1.3 mg/dl) were used as criteria for renal function. At
the time of biopsy there was no difference in mean serum creatinine
levels of the two groups: NT: 1.1 mg/dl; HT: 1.2 mg/dl. During
observation 2 (6%) of the 33 normotensive patients with a mean
creatinine level of 0.9 mg/dl at the beginning developed renal insuffi-
ciency with a mean creatinine concentration of 2.3 mg/dl. In compari-
son, 21 (36%) of the HT group developed renal insufficiency with
primary creatinine levels of 1.3 mgldl and end levels of 3.3 mg/dl. It is
concluded that patients with chronic glomeruionephritis and arterial
hypertension have a significantly worse prognosis concerning renal
function than normotensive patients with GN. The worse prognosis
remains even if the arterial hypertension is adequately treated.
Therapy of idiopathic membranous glomerulonephritis (MGN) with
nephrotic syndrome. M. Przechera, F. Mundlein, G.A. Muller, I.
Zäuner, P. Heering, B. Grabensee, P. Schollmeyer, H. Franz, T.
Ris/er, Departments of Internal Medicine, Universities of Tubingen,
Dusseldorf, Freiburg, U/rn, Germany. The outcome of MGN is uncer-
tain at the time of diagnosis. Therefore there are controversial opinions
about the necessity of treatment. Different regimens of therapy are
debated, and in a number of controlled studies therapeutic effects of
immunosuppressive agents alone or in combination with steroids have
been demonstrated, but the best form of therapy has still to be found.
Therefore we observed 41 patients with biopsy-proven MGN over a
mean follow-up of 4 years comparing natural history with two different
immunosuppressive treatments regarding 24 hr proteinuria, serum
creatinine levels and side effects. Results: Group 1 (10 patients with a
natural history over a mean period of 7.5 years): complete remission 3;
persistant proteinuria without nephrotic syndrome and normal serum
creatinine (partial remission) 2; persistant nephrotic syndrome (PNS) 3;
terminal renal failure 2. Group 2 (combination of prednisone/cy-
closprine A as de Santo; 16 patients over 17 months): complete
remission 3; partial remission 3; PNS 9; terminal renal failure 1. Group
3 (prednisone/chlorambucil as Ponticelli; 15 patients over 39 months):
complete remission 9; partial remission 3; PNS 3. So far best results
were achieved with prednisone/chlorambucil as described by Ponticelli
(80% complete or partial remissions). In 6 cases treated with cyclos-
porn A we observed a relapse of nephrotic range proteinuria after the
end of administration. We started a long-term controlled study to
confirm our results.
Cellular cable analysis in cultured renal epitheloid cells: Influence of
hormones and heavy metals. M. Ritter, G. Grübel, F. Lang, Institute für
Physiologie und für theoretische Physik der Universität Innsbruck,
Innsbruck, Austria. Cellular cable analysis was performed to determine
the cell membrane resistance of subconfluent cultured Madin-Darby
canine kidney (MDCK) cells. To this end three microelectrodes were
impaled into three different cells of a cell cluster. The voltage deflection
in the two neighboring cells following current injection into one cell
allowed the calculation of cell membrane resistance (Rm) and intercel-
lular coupling resistance (Rc). The mathematical analysis utilized an
electrodynamic model derived from Maxwell's equations, In the ab-
sence of hormones and heavy metals Rm approached 2.0 0.2 kflcm2
and Rc 6.1 0.8 Mfl at a cell membrane potential (Vm) of —47.0 0.6
mV. Rm, Rc and Vm were not significantly influenced by the size of the
cluster. Increase of the extracellular potassium concentration and
blockage of K channels by barium, both, depolarized the cell mem-
brane but had the expected opposite effects on Rm without affecting Rc.
Removal of bicarbonate and CO2 hyperpolarized the cell membrane and
decreased Rm and Rc, effects explained by intracellular alkalinization,
which activates K channels in the cell membrane and opens gap
junctions. Epinephrine (1 molIliter), bradykinin (0.1 mol/iiter) and
ATP (10 smol/liter) hyperpolarized the cell membrane and decreased
Rm by activation of K channels in the cell membrane. Cadmium (1
mol/liter) and mercury (1 smol/liter) ions similarly hyperpolarized the
cell membrane and decreased Rm by increase of the K conductance of
the cell membrane.
Immediate increase of glomerular filtration rate following the infusion
of cyclosporine (CsA) in rats. P.M. Rob, H. Page!, J. Fandrey, Depart-
ments of Internal Medicine and Physiology, Medico! University of
Luebeck, Germany. Short term effects of CsA i.v. were examined in
Sprague-Dawley rats. Untreated animals (UNTR; N = 7) were com-
pared to animals pretreated with CsA (30 mg/kg/day, 7 days; TR; N =
9). Controls received the solvent of CsA, Cremophor El (Cr; N = 5).
After determination of baseline GFR and RPF, CsA 30 mg/kg or Cr
were given i.v. in 2 ml 0.9% NaCI over 10 mm. Cr showed no effects.
After 7 days of CsA pretreatment, baseline GFR was decreased
compared to untreated animals (0.58 0.17 vs. 1.27 0.22 mllmin). In
both groups GFR increased within 15 mm after CsA infusion was
started(TR: 0.58 0.17 vs. 1.70 0.34, UNTR: 1.27 0.22 vs. 2.74
0.32 mI/mm) and returned to baseline values within 75 mm. A second
CsA infusion produced the same effects. RPF changed in relationship to
GFR so that filtration fraction remained constant (0.20 0.02). Mean
arterial blood pressure showed little increase from about 105 to 112 mm
Hg. These results indicate that CsA initially acts as an intrarenal
vasodilator or that CsA treated rats have lost their ability of intrarenal
vasoconstriction in response to an increased perfusion pressure.
Biochemical characterization of renal fibroblast subpopulations. H.P.
Rodemann, P. Wecke, L.G. Fine, A. Knecht, J.T. Norman, G.A.
Muller, Developmental Biology, University of Bielefeld, Bielefeld,
Germany; Division of Nephrology, UCLA School of Medicine, Los
Angeles, California, USA; Medical Clinics, Department III, University
of Tübingen, Tubingen, Germany. The existence of prominent intersti-
tial fibrosis in many forms of renal disease reflects the fact that
interstitial fibroblasts are most likely activated by a yet unknown
stimulus to undergo abnormal proliferation and to lay down collagen
and interstitial matrix proteins. The aim of the present study was to
identify and define specific biological and biochemical parameters and
markers of cultured renal fibroblasts established from the renal cortex
and papilla. Subcloning experiments and the analysis of the population
dynamics indicated that papillary fibroblasts (PF-ceils) are character-
ized by a prolonged mitotic life span (25.3 5.5 CPD) as compared to
cortical fibroblasts (CF-cells; 10.4 3.9 CPD). The majority of early
passage PF-cells is made up of mitotically very active cell types MF I
and MF II, whereas CF-cell cultures in comparable passages are
predominantly composed of cell type MF III with low mitotic activity.
By means of 2-D-polyacrylamid-gel electrophoresis of clonal popula-
tions specific intracellular marker proteins of MF III type PF-cells and
MF III type CF-cells could be identified. These differences together
with a differential sensitivity to PDGF indicates that ceilbiological and
biochemical distinct subpopulations of renal fibroblasts exist which may
be of importance in the pathogenesis of renal interstitial fibrosis.
Changes in plasma renin activity (PRA), atrial natriuretic factor (ANF)
and norepinephrine (NE) after acute ACE inhibition in normal subjects.
H. Räwemeier, B. Kutkuhn, F. Kemmer, J. Plum, B. Grabensee,
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Department of Nephrology, Heinrich Heine University, Düsseldorf,
Germany. In contrast to the well studied long-term effects of treatment
with ACE inhibitors on regulation of sodium and volume homeostasis,
little is known about the short-term regulation of these endocrine
systems under acute ACE inhibition. Following a 30-minute rest period,
33 healthy subjects (aged 20—44 years) were given 25 mg captopril by
mouth. Blood samples for determination of PRA, NE and ANF were
obtained at 0, 30, 60 and 180 mm. The blood pressure (BP) and pulse
(HR) were also taken at these times. The PRA increased from 1.6
nglml hr to 3.9 ng/ml hr 60 minutes after captopril (P < 0.001), NE
increased from 176 pg/mt to 252 pg/mi after 60 and 180 minutes (P <
0.001), while ANF fell from 99 pg/mI to 92 pg/ml after 180 mm (P <
0.001). There was a slight drop of 7 mm Hg in BP (mean pressure) after
60 mm (NS) while the HR remained constant. The increases in PRA and
NE and the drop in ANF after acute ACE inhibition cannot be
explained by the changes in BP and HR. The increases in PRA and
adrenergic secretion after administration of ACE inhibitors must be
seen in the context of a negative feedback mechanism in response to the
reduced production of angiotensin II. The decrease in ANF levels under
ACE inhibition can be explained either as the expression of reduced
angiontensin II action or, in accordance with the results of recent
investigations, in terms of adrenergic inhibition of ANF secretion.
Distribution of endogenous, sugar binding proteins in the normal
nephron and in epithelial kidney tumors. C. Seidl, N.J. Gabius, S.
Stoerkel, institut für Pathologie, Mainz and MPI für experimentelle
Medizin, Goettingen, Germany. According to recent investigations,
endogenous, sugar binding proteins (ESBP) are likely to be the physi-
ologic receptors of glycoconjugates in cells. They are involved in
cellular regulation and differentiation. The expression of ESBP was
investigated histochemically in the normal nephron and in renal tumors
(40 renal cell carcinomas -RCC- and 10 oncocytomas) with biotinylated
neoglycoproteins (NGP): xylose-, lactose-, sialinic acid-, GalNAc-,
GlcNAc-, fucose-BSA. All NGP tested reacted with normal renal
epithelium but with varying distribution. Proximal tubules showed no
reactivity, distal parts of the nephron including collecting ducts were
marked with xylose-, lactose-, fucose-, GalNAc- and sialinic acid-BSA.
Single cells in the CD resembling intercalating cells in their pattern of
distribution were stained intensely cytoplasmatic. GlcNAc showed a
weak cellular staining in CNT, CCD and MCD. GIcNAc- and xylose-
BSA strongly reacted with interstitium. Sialinic acid inconstantly
marked cells in the CD nuclear. All NGP reacted with renal tumors
except renal clear cell carcinomas of low malignancy (Gi). The number
of positive cases of clear cell RCC increased with the grade of
malignancy. Chromophilic RCC exhibited a strong and constant expres-
sion of all sugar receptors tested. Chromophobe RCC similarely stained
with all NGP, they showed a mosaic-like pattern with a pronounced
staining reaction at the cell membrane. Oncocytomas showed a strong
staining reaction with xylose-, lactose-, GIcNAc- and sialinic acid-BSA
and weak staining with GalNAc and fucose-BSA. Chromophobe RCC
and oncocytomas therefore have an intercalated cell-associated pattern
of NGP expression. This lends further support to the collecting duct
(intercalated cell) histogenesis of these tumors.
Image analysis of renal tissue angiotensinase A in patients with pro-
gressive kidney diseases. J.E. Scherberich, A. Matthej3, G.H. Thoenes,
W, Remelius, W. Schoeppe, Department of Nephrology, University
Hospital and Zeiss comp., Frankfurt/Main, Med. University of
München, Germany, To elucidate possible adaptive changes of renal
cells in various stages of progressive kidney diseases, the tissue
expression of glomerular and tubular angiotensinase A (ATA)—a 210
kDa glycoprotein—was analyzed applying quantitative VIDAS-Zeiss-
Kontron image analysis equipment. The calculations were based on a
modified software package where the exclusive glomerular but not the
tubular ATA-positive (ATA+) compartment was assessed. After spe-
cific staining for ATA activity 3 to 4 representative areas of each of the
kidney sections were analyzed. Image analysis of glomerular ATA of
the following groups was performed: (1.) 497 glomeruli of 7 normal
kidneys; (2.) 978 glomeruli of tissue sections from 34 pats. with various
slight to medium kidney damage (hypertension, arteriolosclerosis,
serum creatinine <3 mg/dl); (3.) 405 glomeruli of 19 kidneys from pats.
with severe renal injury (creatinine >3 mg/dl). In normal controls the
mean ATA+ area of a single glomerulus was (23.9 8.4) x 103/,2 and
was significantly larger in the clinical groups: group II, 29 >< 103/2 (N
= 978), group III, 33 x i0/ (N = 405). However, the total ATA+
glomerular compartment was reduced in both of the pathological
groups: controls (N = 28)6 1.8area%; group II (N = 132) ATA+ 5.0
1.6 area%, group III (N = 90) ATA+ 3.4 2 area% (2P < 0.01). In
addition, using another software, the ATA-negative interstitial area
rose significantly from group Ito group 3: group I (controls, N = 60) 27
8 area%, group 2 (N 136)53 13 area%, group 3 (N 80)84 12
area%. These data support the idea that tubulointerstitial damage
parallels the progression of kidney diseases. In an additional 42 pats.
with variouis forms of glomerulonephritis the glomerular ATA synthe-
sis was highly impaired especially near capsular proliferates and infil-
trations; the regular ATA distribution profile was abolished. The results
indicate that (1.) irrespective of the progression of the underlying
disease surviving remnant nephrons exhibit hypertrophic glomeruli
with high and homogeneous expression of ATA; (2.) the total ATA+
glomerular compartment is reduced, however; (3.) the ATA— renal
interstitum is significantly augmented in advanced chronic renal failure.
Survival of glomeruli in progressive nephritis may thus correlate with
the capability of podocytes/endothelia to synthesize ATA at an in-
creased rate.
Patterns of serum- and kidney-specific protelnuria in patients with lily
infection. J.E. Scherberich, A. Schneider, A. Nockher, S. Staszewski,
W. Schoeppe, Department ofNephrology, Center of Internal Medicine,
J. W. Goethe-University, Frankfurt am Main, Germany. To elucidate
possible renal involvement in 300 patients (254 men, 46 women)
infected with HIV (+ anti-HIV antibodies), in addition to routine
parameters, the urinary excretion of the following markers was studied:
angiotensinase A (ATA) of glomerular and tubular origin, brush border-
bound alanine-(glyleu-)amino-peptidase (APM), gamma-glutamyl-trans-
peptidase (GGT), dipeptidylaminopeptidase-IV (DAP IV, CD26); im-
munoglobulin G (IgG), albumin and a1-microglobulin (aim), all
calculated as protein/creatinine ratio (U mg/mmol creatinine). In addi-
tion, patterns of proteinuria were assessed by SDS-polyacrylamide gel
electrophoresis (SDS-PAGE) using PHAST system (gel gradient
5—20%) equipment and sensitive silver staining of protein bands.
Eighty-two healthy persons and 148 pts. with various kidney diseases
served as controls, among them those suffering from glomerulonephritis
(N = 44), interstitial nephritis (N = 23) or connective tissue diseases (N
= 18). Stages of HIV-disease were defined according to Brodt et al,
1986. Nephron marker proteins ATA, APM, GGT, DAP IV showed an
enhanced urinary excretion rate which was positively correlated with
the progression of HIV disease, especially between stage ha (LAS) and
stage III (full blown AIDS; 2P < 10). Multiple rank analysis revealed
that individual parameters (e.g. DAPIV, a1m) measured in HIV+ pts.
differed from values found in healthy controls or in pts. with glomeru-
ionephritis and interstitial nephritis, respectively (2P < 0.05—0.0001).
The increased excretion of IgG, albumin and a1m also paralleled the
stage of HIV infection. In 289 HIV+ pts. the following pathological
pattern of proteinuna (SDS-PAGE) was apparent: stage ha 16/45(35%),
stage IIb 69/127 (54%), stage III (96/117 (82%). Compared to glomeru-
lotubular proteinuria (17%), tubular proteinuria (42%) was most fre-
quently present in all of the HIV+ pts. tested and differed (follow up
studies) from that of HIV+ i.v. drug abusers. From 88 HIV+ pts.
without any medication, 35% disclosed a pathological profile of pro-
teinuria (SDS-PAGE). After 24 to 29 months the frequency of protein-
uria in 30 HIV+ pts. increased from 43% to 87%. Except in terminal
AIDS, serum creatinine did not significantly differ among the HIV
stages. The data support the idea that tubulointerstitial lesions are
commonly observed in HIV+ pts.
Does normal activity of succinate dehydrogenase (SDH) exist in renal
mitochondria of cyclosporine A (CsA) treated rats? H. Schmid, H.
Schmitt, R. Eissele, G. Neuhaus, institute of Pathology, University of
Tubingen, Tübingen, Germany. The reports on the degree of CsA
induced changes in mitochondrial function of rat kidneys are contra-
dictory. By histochemical investigation, we have found tubules with
CsA induced reduction of SDH activity in defined regions as well as
tubules with apparently normal SDH activity, the number of the latter
decreasing with the CsA dosage (Nieren- und Hochdruckkrankheiten
15:376, 1986). In these tubules, we determined SDH activity by
microphotometric evaluation of stained renal sections of 32 male
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Sprague-Dawley rats treated orally with CsA (15, 30 or 50 mg/kg day)
or olive oil (30 mg/kg day) for 12 or 24 days or left untreated for 24
days after 24 days of CsA administration. In 13 nephron segmeents, we
found exclusively normal relative SDH activity (SDH activity of a
segment per SDH activity of the collecting duct in the inner stripe of the
outer medulla) in the controls and after discontinuation of CsA. After 12
and 24 days of CsA administration, all the animals exhibited normal
SDH activity along the nephron, but with individual variations: in the
glomeruli and collecting ducts, in some of the distal tubules of the
cortex and outer stripe of the outer medulla, in the majority of proximal
convoluted tubules and thick ascending limbs of Henle's loop in the
inner stripe of the outer medulla, but only in few cortical and medullary
proximal straight tubules. The existence of a relatively high proportion
of tubules with normal SDH activity may explain the difficulties to
detect CsA induced affection of succinate-dependent respiration.
Autovaccination In patients with recurring urinary tract infections. R.
Schmidt, H. Schmidt, U. Falkenhagen, R. Claus, M. Seyfarth, G.
Naumann, H. Klinkmann, Department of Internal Medicine, Institute
of Microbiology, Institute of Immunology, University of Rostock,
Rostock, Austria. If recurrences or reinfections of urinary tract infec-
tions (UTI) become frequent, treatment can be problematic. A new way
of treatment seems to be immunostimulation. Studies with a polyvalent
vaccine did not result in a desired success. Eleven patients with E. co/i
UTI showing a frequency of recurrence of 6.3 1.1 per year underwent
autovaccine therapy. From the patient specific E. coli germ, a de-
stroyed full germ vaccine (concentration 8 x io germs/mi) was
produced. A dose of 0.5 ml of the vaccine was administered intramus-
cularly 3 times in weekly intervals. Success of treatment was assessed
by the recurrence rate. An extensive immunological monitoring showed
the dimension of immunostimulation. Vaccination itself was well toler-
ated. Rate of recurrence decreased to 2.8 2.3 episodes per year after
vaccination. In cases of recurrence 82% of the patients showed a
change in serum type of the germ. In 86.2% there was an increase of
secretory IgA in urine, in 76.1% a complement activation (alternative
pathway) was observed and in 91.2% an activation of monocytes (Latex
phagocytosis, interleukin 1 secretion) was found. A booster vaccination
after 6 months seems to be necessary.
Differential effects of renal vasoconstrictors on renin secretion from
isolated perfused rat kidneys. H. Scholz, B. Kaissling, A. Kurtz,
Physiologisches und Anatomisches Institur der Universität, Zurich,
Switzerland. In this study we have investigated whether an increase of
renal vascular resistance is generally associated with an inhibition of
renin release. Using the isolated perfused rat kidney, the effects of three
different vasoconstrictors—angiotensin II (Ang II), arginine vasopres-
sin (AVP), and potassium depolarization—on renal vasotone and renin
secretion were studied. Isolated rat kidneys were perfused at constant
pressure of 100 mm Hg in a recirculatory system. The perfusion
medium containing 2 g/dl bovine serum albumin and a 10% fraction of
human erythrocytes was continuously dialyzed against a 20-fold volume
of protein-free saline. Basal flow rate through isolated kidneys was 14.5
2 mi/mm x g, basal renin secretion rate was in the range of 28.8 6.1
ng Ang I/hr per mm and g (X SEM, N = 6). Ang 11(100 pM), AVP (1
nM), and KCI (30 mM) all decreased renal flow rate to 42 2%, 29
3%, and 20 4% of control, respectively (N = 5 each). Ang II induced
renal vasoconstriction was accompanied by a 70% reduction of renin
secretion, whereas AVP caused a 5-fold increase of renin release. KCI
(30 mM) had no effect on renin secretory rates. Our findings suggest that
there is no general inverse correlation between renal vasotone and renin
secretion. Moreover, potential operated calcium channels do not seem
to play a functional role in the control of renin release from isolated
perfused rat kidneys.
Strongly reduced levels of urinary Tamm-HorsfaH protein in the
hyperprostaglandin E syndrome: Selective damage of the distal tubule? J.
SchrOter, H. W. Seyberth, G. Timmermans, J. Greven, S. Bachmann,
Department of Anatomy and Cell Biology, Heidelberg; Children's
Hospital, University of Marburg; Department of Pharmacology,
Aachen, Germany. The hyperprostagiandin E syndrome (HES) resem-
bles the Bartter syndrome (BS) in many aspects. Similar to BS, liES is
characterized by congenital hypokalemic alkalosis, hypertrophy of the
juxtaglomerular apparatus, hyperreninemia, secondary hyperaldoster-
onism, normal blood pressure and renal diabetes insipidus. Other than
BS, HES specifically reveals chronic hypercalciuria and nephrocalci-
nosis as well as both renal and systemic PGE2 overproduction. Correc-
tion of most of the symptoms in HES is achieved by chronic PG-
inhibition with indometacin (Indo). Urinary Tamm-Horsfall protein
(THP) was measured by ELISA in infant HES patients (age 2 months-.8
years, = 5.2 years): Nine HES patients under constant Indo treatment
(A1) and after one week period without Indo (A2). Nine healthy children
(B; age 5—8 years) served as controls. THP excretion in HES was
strongly diminished: (A1) = 9.0 (median 3.5) mg/24 hr/I .73 m2 body
surface, (A2) = 12.7 (median 7.2) mg/24 hr/i.73 m2, (B) 5i 54.0
(median 46.0) mg124 hr/i .73 m2. Values in (A1) and (A2) were signifi-
cantly different from (B) (P  0.001), however, there was no significant
difference between (A1) and (A2) (Mann-Whitney U and Wilcoxon test).
Creatinine clearance was 81.9 (median 83.0) mI/mm in (A1), 75.1
(median 76.2) mI/mm in (A2). In (B) no values were obtained. Compar-
ative measurements of THP excretion in two infant classical BS-
patients revealed normal THP values (51.2 and 47.3 mg/24 hr/i .73 m2).
Immunocytochemistry in renal biopsies of 3 of the HES patients
showed a strong reduction in tubular THP immunoreactivity in two
cases, less clear reduction in the third one. In situ hybridization using a
THP-riboprobe revealed significantly reduced or absent THP-mRNA
levels in HES renal biopsies. The severely decreased THP production
in HES together with moderately but not extensively reduced renal
function point to a selective contgenital defect of the distal tubule.
Thus, HES appears to be a separate entity clearly distinguished from
the classical BS. Earlier assumed relations between nephrocalcinosis
and THP abnormalities are confirmed by the results.
Receptor mediated endocytosis of albumin in cultured kidney cells
(OK): A model for proximal tubular protein reabsorption. J.S. Schweg-
ler, S. Silbernagl, with the technical assistance of S. Mildenberger,
Physiologisches Institut der Universität Wurzburg, Wurzburg, Ger-
many. The accumulation of fluorecein labeled (FITC) bovine albumin
was measured in the proximal tubular opossum kidney cell line OK.
The marker was found to be distributed in a vesicular form in the
intracellular space. The intensity of intracellular fluorescence rose
linearly during the first 30 mm of incubation with FITC albumin and
reached saturation after 2 hr. The initial FITC albumin uptake was
saturated at 1000 mg/liter (vmax = 3.0 0.3 pg/mg proteinll5 mm; N =
4). Half-maximum uptake occurred at 50 mg/liter. In contrast, the
activity of fluid phase endocytosis (measured with FITC inulin) was 15
times lower than FITC albumin uptake. Cytochalasin B (10 mol/liter,
I hr) reduced FITC albumin uptake to 57 8% (N = 7). Preincubation
in serum free culture medium for 24 hr stimulated albumin endocytosis
by 67 1% (N = 3). OK cells were found to possess a specific
mechanism for the endocytosis of proteins which exhibited the kinetic
properties of a receptor binding process. The endocytosis of albumin
required an intact and is partially inhibited by serum components.
Expression of probenecid-inhibitable p-aminohippurate and sodium
dependent sulfate transport in oocytes of Xenopus Iaevis after injection of
mRNA from rat kidney. J. Steffgen, W. Schwarz, H.E. Franz, H.
Koepsell, Sektion Neprologie, Universitdt UIm, MPI fur Biophysik,
Frankfurt, Germany. At present, information about the molecular
structure of the renal transport systems for p-aminohippurate (PAH)
and sulfate is missing. Therefore, we tested whether the expression of
a cloning method may be used to clone these transport proteins. Each
oocyte was injected with about 50 ng poly(A) RNA and incubated at
18°C. Three days after injection, total 3H-PAH uptake was stimulated
by a factor of 2.2 0.1 (6 injections) in comparison to non- or
water-injected oocytes from the same animal. About 90% of the
stimulated PAH transport could be inhibited by 5 m probenecid. The
expressed transport showed a higher affinity to PAH than the endoge-
nous one (apparent Km = 0.1 m vs. 2 mM). Preincubation of the
oocytes at 30°C for 3 hr before influx measurements led to a further
twofold increase of PAH uptake in the injected oocytes, whereas the
endogenous transport increased only 1.3-fold. Transport of total
35S042 could be stimulated by a factor of 2.5 0.15 (4 injections);
about 85% of this stimulated transport was sodium dependent. After
size-fractionation of mRNA on a 1% agarose gel, mRNA of 1.5—2.5kB
stimulated the sodium-dependent sulfate transport by a factor of about
18.3. These results show that after injection of mRNA from rat kidney
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into oocytes of Xenopus laevis, probenecid-inhibitable PAH and sodi-
um-dependent sulfate transport can be expressed.
Effect of eicosanoids on electrIcal properties of cultured renal epitheloid
(MDCK) cells. M, Steidl, F. Lang, Institut für Physiologie der Univer-
sität Innsbruck, Innsbruck, Austria. The present study was designed to
disclose a possible effect of eicosanoids on ionic conductances in
Madin-Darby canine kidney (MDCK) cells. To this end the potential
difference across the cell membrane (PD) was continuously monitored
in subconfiuent MDCK cells, using conventional microelectrodes (150
Mohm). In the absence of exogenous eicosanoids PD approached —47.4
1.3 mV (N = 50). Application of I prnol/liter arachidonic acid (AA)
lead to a transient initial hyperpolarization (by —3.0 1.2 mV, N = 21),
followed by a slight depolarization (+2.9 0.7 my) and a second,
sustained hyperpolarization (——5.5 0.8 mY). Indomethacin (1 mol/
liter abolished, and 0.1 mol/liter indomethacin blunted the action of
AA. POE2 (1 mol/liter) lead to a transient hyperpolarization of the cell
membrane by —14.3 2.1 mV (N = 7), followed by a transient
depolarization (+3.4 0.9 mY), with a time course virtually identical to
the time course of AA induced PD changes. PGF2, (1 smol/liter) lead to
a slow, sustained hyperpolarization (by —5.7 1.5 mV, N = 7) similar
to the second AA induced hyperpolarization. The transient PGE2
induced hyperpolarization was paralleled by a decrease of input resis-
tance by —9.1 2.1 Mohm, the slow PGF2, induced hyperpolarization
by an increase of the cell membrane potassium selectivity. In conclu-
sion, AA hyperpolarizes the cell membrane via intracellular formation
of PGE2 and PGF2, possibly by activation of potassium channels. The
action of POE2 is immediate and transient, the action of PGF2,. delayed
and sustained.
Channel mediated base secretion in renal epithelial cells. W. Steigner,
U. Kersting, H.-J. Westphale, H. Oberleithner, Department of Physi-
ology, University of Wurzburg, Würzburg, Germany. One important
function of the kidney is the control of blood pH. The mechanism for
secreting alkali (as HCO) appears to be insensitive to antibodies
against band 3 proteins. So it is unlikely that the apical Cl/HCO
exchanger mediates HCOç secretion exclusively. Alternatively, we
now describe an 11C03 channel in fused MDCK cells, which resemble
intercalated cells of the collecting duct. We measured single channel
currents and the HCOj conductance of dialyzed (whole-cell patch
clamp) and intact (microelectrode technique) cells. The single channel
measurements (excised patch, i/o) disclose a HCOç selective ion
channel (selectivity ratio HCO:Cl 8:1), which is stimulated by
depolarization of the membrane potential and by increased intracellular
C1 concentration. Single channel conductivity is 18.6 5.6 pS (N = 5)
at an open probability of 0.2 (Vm = —30 mV; Cl 110 mM). Measure-
ments of the HCO conductance of dialyzed (0.9 0.4 nS; N = 3) and
intact (—3.2 nS) cells confirm the existence of a HCO3 channel. Based
on these data 250 HCO channels per dialyzed cell and 990 channels per
intact cell can be calculated. We conclude that HCO3 channels can
contribute to tranepithelial base secretion and to the pH homeostasis of
the organism.
Effects of protein load on renal hemodynamic response in renal failure
(RF) and human pregnancy. G. Stein, R. Hartung, G.-J. Fleischhauer,
A. Seidel, E. Ritz, M. Schmid, H.-J, Seewald, Department of Internal
Medicine, University Jena and Heidelberg, Department of Obstetrics,
University Jena, Germany. The effect of a high protein load was
investigated in 6 controls (S 88 9 smol/liter), 6 patients with renal
failure (Sr 186 28 imoI/liter) and 10 patients with pregnancy (Se. 54
4 molIliter), GFR was measured by Cth and E1PF by CPAH during
basal state and for 3 hr following a protein meal (1 g/kg, as cooked red
meat). Following protein load an increase of GFR (130 vs. 153 ml/min/
1.73 m2) and ERPF (539 vs. 627 mllminll73 m2) was seen in controls.
Paradoxically, GFR decreased (73 vs. 60 mI/mm/i .73 m2) in patients
with RF, whereas ERPF remained unchanged. In pregnant women
basal values of GFR and ERPF were high and increased following the
mean (GFR 181 vs. 236; ERPF 534 vs. 733 mI/mm 1.73 m2). There was
no correlation to changes of plasma amino acid pattern. In conclusion,
acute protein load raises GFR in normal persons and pregnant women,
but tends to paradoxically lower GFR in renal failure.
Correlation between course and morphology in infant purpura
nephropathy. R. Waich, W. Meerbach, A. Lemmer, Children's Hospital
and Institute of Pathology of the Medical Academy Erfurt, Germany.
During infancy, the nephropathy Henoch-SchUnlein purpura usually is
supposed to have a good prognosis. Sixty-four children with anaphy-
lactoid purpura had been treated from 1978 to 1990 at our hospital.
Twenty-one of these patients presented significant renal involvement.
The onset of the disease in this group of patients was between 4 and 12
years of age (average 8 years). Percutaneous biopsy of the kidney was
performed in the 14 ''. who developed heavy proteinuria (>1 g/ml
day), sometimes in association with neurological symptoms, such as
hypertonus. Histologically, II children showed focal segmental mesan-
gio-proliferative glomerulonephritis (ON). Three cases showed more
extensive glomerular damage with sclerosis. In one additional case a
severe focal GN with necrosis of the loops, cicatrization and synechia
with the capsule of Bowman was present. By immunocytochemistry
IgA and human globulin, but not 1gM, IgG or C3-complement were
detected in 5 out of 9 patients examined. Two patients with a clinical
course characterized by heavy proteinuria and severe hypertension
developed rapidly progressive GN and chronic renal failure, requiring
dialysis. Our study suggests the need for close follow up in patients with
Henoch-Schonlein purpura until adulthood.
Multicenter study with nitrendipine in 125 hemodialysis patients with
hypertension. E. Wandel, E. Zyzik, F. Himmeisbach, H. Dumann, E.
KOhIer, H. KOhier, I. Medical Department, University of Mainz,
Mainz, Germany. The aim of the multicenter study over 6 months in 25
dialysis centers was to show the efficacy and side effects of monother-
apy with nitrendipine in hemodialysis patients with hypertension (dia-
stolic blood pressure > 95 < 115 mm Hg). Of interest was to determine
the dosage of nitrendipine monotherapy for blood pressure normaliza-
tion. Monotherapy is useful due to the lack of reflextachycardia in
hemodialysis patients, resulting from uremic sympathetic dysfunction.
The antihypertensive effect is very strong without tachycardia. One
hundred and twenty-five hemodialysis patients (73 m, 52 f) mean age
54.8 13.7 years, with hypertension were examined. Patients suffered
from chronic glomerulonephritis (N = 30), chronic pyelonephritis (N =
20), nephrosclerosis (N = 25), sclerotic kidney of unknown origin (N =
37), and diabetic nephropathy (N = 13). The primary concomittant
disease was coronary heart disease (N = 25). Medium dry weight
amounted to 66 11.7 kg, interdialytic variations were 3 1.5 kg.
Hypertensive hemodialysis patients were treated with nitrendipine for 2
tofl months, initially with 10mg, and in case of no response, the dosage
was increased to 40 mg at 3 week intervals. Blood pressure and heart
rate were registered twice a week before and after hemodialysis
treatment. Fundoscopy was performed at the beginning and at the end
of the study. Sixty patients were treated up to 2 months, 65 patients up
to 6 months, Diastolic blood pressure decreased from 104 4.5 mm Hg
to 84 9.5 mm Hg after 6 months with a response rate of 76%. Blood
pressure normalization was achieved with 10 mg nitrendipine (N = 18),
by 20 mg (N = 24), by 40 mg (N = 23). In those patients with 2 months
of treatment, blood pressure decreased only to 89 17.5 mm Hg with
a response rate of 60%. In 27 patients side effects were reported; in 10
cases therapy was stopped. In 17 patients fundoscopy showed an
improvement. No pathological laboratory data were registered. In
conclusion, the multicenter study demonstrated that nitrendipine is a
safe therapy for hypertension in hemodialysis patients and suitable for
monotherapy. After 6 months treatment a significant decrease of blood
pressure is seen with a response rate of 76%.
Dialysis related amyloidosis, secondary hyperparathyreoidism—A long
term study on 183 hemodialysis patients. F. Wandel, E. Zyzik, S.
Schadmand, A. Elsen, G. Scherer, H. KOhIer, 1. Medical Department,
Institute of Radiology, University of Mainz, Mainz, Germany. Dialysis
related amyloidosis-type AB = /32-microglobulin is a known complica-
tion in long term hemodialysis treatment. Bone cysts, pathological
fractures, destructive arthropathy, musculoskeletal syndromes and
car-pal tunnel syndrome are typical signs as well as the high discrepancy
between joint destruction and low inflammatory reaction of surrounding
tissue. f32-microglobulin can be detected by immunoblot analysis in
these tissues. Another known long-term complication is secondary
hyperparathyroidism. The aim of our study was to find the localization
of amyloid osteoarthropathy and hyperparathyroidism and the mci-
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dence in hemodialysis patients. We examined retrospectively 185
patients on chronic hemodialysis treatment (no CAPD) over 14 years on
the basis of X-rays, analysis of synovial tissue, PTH, calcium, alkaline
phosphatase, and by analysis of documented pain. In 83 patients the
diagnosis of HPT was proven. AC joints (55%), hands and fingers
(36%), and spine (15%) were mainly affected. Thirty-five patients were
predialytic at first diagnosis, and 48 patients were on continuous
treatment for more than 7 years. PTH was <1000 pmol/Iiter in 68% and
in 15% >3000 pmol/liter. In 32 patients we found the tpical signs of
amyloid osteopathy. Time of treatment was more than 8 years. Twenty-
nine patients showed an associated carpal tunnel syndrome treated by
operation, 3 patients an associated hyperparathyroidism. The immune
histochemical analysis of the synovial tissue revealed amyloid type AB
(i32m), associated with hyperparathyroidism in 3 patients. Pain was
localized in humerus, femur, cervical and thoracic spine. Bilateral pain
due to amyloidosis was found. In hyperparathyroidism, pain was
associated with movement. Dialysis realted amyloidosis is a complica-
tion in hemodialysis treatment after more than 8 years. Hyperparathy-
roidism is also seen in predialytic patients. Differentiation of the long
term complications is significant, aiding in treatment decisions. X-ray
analysis, pain characterization, laboratory data, and time of dialysis
treatment allow the differentiation of long-term dialysis-associated
complications.
Osteocalcin (BGP) levels in renal osteodystrophy: Relationship to
serum albumin and other markers of bone metabolism. G. Warneke, M.
Barth, H.V. Henning, R. Verwiebe, B. Kraft, F. Scheler, Zentrumfiir
Innere Medizin, Georg-A ugust- Universitiit, Gottingen, Germany. Os-
teocalcin, or bone GLA protein (BGP), is a 49 amino acid protein with
a molecular weight of 5845 daltons. It is synthesized by osteoblasts and
is cleared from the serum by the kidneys. Serum levels of BGP can be
measured using a homologuous human carboxy-terminal hBGP-(37-49)
radioimmunoassay, and have been found to be the most specific and
sensitive biochemical parameter of bone formation, in particular of
osteoblast activity in healthy males. To investigate the relationship of
BGP to serum aluminum and other markers of bone metabolism we
measured the serum concentrations of ionized calcium, total calcium,
magnesium, inorganic phosphate, alkaline phosphatase, parathyroid
hormone (intact and mid-molecular assays), aluminum and BGP in 40
patients on chronic maintenance hemodialysis. Serum BGP concentra-
tions in a control group of 40 healthy males, 32 11 (range: 20—50)
years of age, were 8.15 4.36 ng/ml. Significant correlations were
found between serum BGP levels and serum concentrations of intact
(1-84) parathyroid hormone (r = 0.73; P < 0.01), midmolecular (44-68)
fragments of parathyroid hormone (r = 0.69; P < 0.01), total calcium (r
= 0.38; P < 0.01) and ionized calcium (r = 0.35; P < 0.01). The
relationship between serum BGP and alkaline phosphatase (r = 0.17; P
<0.10), magnesium (r = 0.10; P > 0.33) and inorganic phosphate (r =
0.09; P> 0.34) showed only weak or no significant correlations. Serum
concentrations of aluminum and BGP showed a significant inverse
correlation (r =
—0.71; P < 0.01). In our patient group two different
clusters regarding serum aluminum and BGP levels were found: (1.) Al
<50 ng/ml; BGP = 232.64 110.87 ng/ml; N = 23; and (2.) Al > 150
ng/ml; BUP = 56.12 40.43 ng/ml; N = 6. In conclusion, BGP is a
highly specific and sensitive biochemical parameter of bone formation
and osteoblast activity in renal osteodystrophy, furthermore, BGP
might have a high predictive value indicating an aluminum induced
inhibition of bone mineralization following parathyroidectomy in pa-
tients suffering secondary hyperparathyroidism.
Aluminum, iron, copper and zinc levels in hemofiltration patients after
deferoxamine infusion. G. Warneke, D. Sdlter, R. Verwiebe, H. V.
Henning, B. Kraft, F. Scheler, Zen trum für Innere Medizin, Georg-
August-Universitat, Gattingen, Germany. Dialysis patients suffering
from aluminum overload are treated with deferoxamine (DFO) to
release aluminum from its protein binding sites (80—90%), thereby
making it filtrable. Besides aluminum (binding affinity 1021), iron (Fe3
1028, Fe2 lOb), copper (Cu2 1014) and zinc (Zn2 10fl) are also bound
to DFO. Serum levels and filtrability of these elements should therefore
change under DFO treatment. Investigations on 15 patients undergoing
chronic hemofiltration (HF) (9 male, 6 female; age 52.8 14.9 years;
weight 59.3 10.2 kg; duration of HF 41.3 31.7 month) showed that
treatment with 10 mg DFO kg/body weight significantly increased the
elimination of aluminum, 718 41% (P < 0.001), andiron, 478 265%
(P < 0.001). The correlation between aluminum and iron elimination
was negative (r = —0.77, P < 0.002), On the other hand the elimination
of copper and zinc decreased significantly to 86 24% (P < 0.00 1) and
81 5% (P < 0.001), respectively. We conclude that under DFO
treatment aluminum and iron compete for DFO binding while having a
negative balance, and that copper and zinc are eliminated significantly
less efficiently, despite high binding affinity to DFO. Copper may be
bound more tightly to serum proteins during DFO therapy while zinc
moves from serum into other compartments, erythrocytes preferen-
tially take up zinc through binding to carboanhydrase. Zinc concentra-
tions in erythrocytes were up to 15 times greater then in serum.
Frequency of anti-GBM antibodies (AB) in Wegener's Granulomatosis
(WG) and of anti.neutrophil-cytoplasmic antibodies (ANCA) in Good-
Pasture's syndrome (GP). M. Weber, K. Andrassy, 0. Pullig, J.
Koderisch, Universities of Erlangen-Ndrnberg, and Heidelberg, Ger-
many. The diagnosis of pulmo-renal ryndrome has been improved by
the demonstration of anti-GBM AB and ANCA. In a recent report,
ANCA were found in 30% of anti-GBM AB-positive sera. Conversely,
in 8% of ANCA-positive sera, anti-GBM AB were also present.
However, the ANCA-RIA did not discriminate between C-ANCA and
P-ANCA (C = cytoplasmic, P = perinuclear staining). In addition, the
anti-GBM RIA was performed with a collagenase digest of GBM as
crude mixture of antigens. It was the aim of this study to address the
question of ANCA in GP and anti-GBM AB in WG with more specific
assays. Sera from patients with biopsy proven WG (N = 31) and GP (N
= 19) were analyzed. ANCA were demonstrated by indirect immuno-
fluorescence (hF). In addition, MPO-antibodies (P-ANCA) and
C-ANCA were analsed by EIA, the latter according to Rasmussen et al.
Anti-GBM AB were detected by EIA using the globular domain NC1 of
collagen IV as antigen. In 19/19 GP sera, anti-NCI AB could be
demonstrated. One serum was also positive for C-ANCA (EIA and
IIF). In this case, extraglomerular vasculitis was additionally present on
renal biopsy. In 7/19 sera, low titers of anti-MPO antibodies were
detected by EIA, while hF was negative. No signs of extraglomerular
vasculitis were found. In 3 1/31 WG sera, ANCA were demonstrable by
IIF. Twenty-nine of 31 showed a C-ANCA pattern, 24/31 were also
positive in the C-ANCA EIA. Two of 31 were P-ANCA positive by hF
and had anti-MPO AB by EIA. In one of these sera, C-ANCA were also
found by EIA (double positive). No sera of WG patients showed
anti-NC 1 AB. The results indicate: (1) anti-NC I antibodies are specific
for GP. (2) C-ANCA are highly indicative of WG. (3) Low-titers of
anti-MPO antibodies occur in about 1/3 of patients with GP. (4)
Presence of anti-NC 1 AB and C-ANCA may occur when GP is
associated with extraglomerular vasculitis.
Assessment of iron metabolism by iron kinetic studies in HD patients
under rHuEPO therapy. B. Weitz-Miesner, T. Tsobanelis, P. Kurz, B.
Roth, E. Werner, J. Viachojannis, P. Grützmacher, St. Markus Hos-
pital, GSF, Frankfurt/Main, Germany. Iron deficiency frequently oc-
curs under acute and chronic recombinant human erythropoietin
(rHuEPO) therapy for dialysis-associated anemia. In 12 HD patients
with renal anemia, rHuEPO was given three times weekly intrave-
nously after hemodialysis. The dosage was 40 lU/kg body wt. We
studied changes in iron metabolism during acute correction of renal
anemia by iron kinetics. Iron kinetic studies were performed before and
after 4 weeks of rHuEPO treatment. After plasma labelling with 59Fe
hemoglobin synthesis rate (Hb-SR, g/day), marrow iron turnover (MIT,
mg/day), red cells iron turnover (RCIT, mg/day) and iron tissues
turnover (TIT, mg/day) were calculated using a multi-compartment
model of internal iron turnover. The table indicates a significant rise of
Hct and a significant decrease of ferritin and transferrmn saturation after
4 weeks of rHuEPO treatment. Iron kinetics further showed a signifi-
cant increase of HbSRa (+25%), MIT" (+24%) and RCIT" (+25%)






Before 22.2 0.5 1002 338 38.8 6.8 4.16 0.5
After 27.9 1.3 429 158 22.2 3.7 5.90 0.5
a P < 0.01, b P < 0.005.
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We conclude that after rHuEPO therapy the need for rapidly available
iron increases, thus leading to a relative iron deficiency. As tissue iron
deposits are mobilized slowly high serum ferritin levels do not preclude
acute iron deficiency. Iron substitution should be monitored by mea-
suring transferrin saturation.
Negative functional and structural effects of nitrendipine on the con-
tralateral kidney in rats with renovascular hypertension. U.O. Wenzel,
G. Troschau, B. Ebert, U. Helmchen, U. Kneissler, W. Schoeppe, G.
Schwietzer, Departments ofNephrology and Pathology, Universities of
Frankfurt a.M. and Hamburg, Germany. The behavior of the preglo-
merular resistance (RA) during antihypertensive therapy is probably
one important factor for the glomerular capillary hypertension and
hence for the progression of glomeruloscierosis (GS). Therefore, we
studied the functional [inulin and PAH clearance, albuminuria (ALB)]
and structural changes after therapy (6 weeks) with the CEI enalapril
(ENP) or the calcium antagonist nitrendipine (NIT) in a model of
hypertension with a high basal RA (contralateral kidney, 2-kidney, one
clip hypertension, 6 weeks duration) compared to normotensive (NC)








NK 125 3 4.7 0.6 1.6 0.2 7.3 2 0.1 0.03
HK 192 7C 8.7 2 1.8 0.3 10.7 3 1.3 0,4b
ENP 143 6a.e 11.7 6 1.9 0.3 13.7 4 0.9 05b
NIT 183 1OC 109.4 55d 1.7 0.2 11.2 3 3.8 1,1d
Data are means SEM. a P < 0.05, bp< 0.01, P < 0.001 vs. NC;
d P < 0.01 vs. NC, HC, ENP; e P < 0.01 vs. HC, NIT.
ENP induced a decrease of SBP and an increase of RPF but no changes
of ALB, GFR and GS. In contrast, NIT caused no changes in SBP but
a marked increase of ALB and GS without effect on glomerular
hemodynamics. In conclusion this study shows that untoward chronic
renal effects of vasodilatators could exist if there is no or only small
blood pressure decrease. NIT may have accelerated progression of
hypertensive glomerular changes and albuminuna in this model of
hypertension by afferent dilatation causing glomerular capillary hyper-
tension.
Aminopenidihins and gyrase inhibitors influence cyclosporine pharma-
cokinetics. A. Westhoff, B. Munsch, B. Grabensee, Department of
Nephrology, Heinrich-Heine-University Düsseldorf, Germany. Be-
cause of its marked pharmacokinetic variability controlled treatment
with cyclosporin A (CsA) still presents a problem. In case reports
unexpected excesses of cyclosporine levels have been reported under
therapy with various additional antibiotics. In 5 patients we examined
the influence of treatment with ampicilline/amoxycilline or ofloxacine
on the cyclosporine pharmacokinetics. The kinetic parameters were
measured in all patients under a constant CsA dose shown in a 12-hr
concentration profile during and 10 days after antibiotic therapy. CsA
whole blood levels were determined by radioimmunoassay. CsA phar-
macokinetics during ampicilline/amoxycilhine treatment: A mean in-
crease of 90% (±59%) showed a correlation to a simultaneous (36%
20%) decrease of the distribution volume. The relative bioavailability
calculated by the area under the CsA concentration curve increased
under antibiotic influence (+28%; 7.2—54.2%), Corresponding to these
results, the total body clearance fell (—20%; 7.5—35.1%). The increase
of the CsA peak level (41.5 6.0%) as a result of the reduced
distribution volume explains the improved bioavailability. The t112
showed no clear pattern of change. CsA pharmacokinetics during
ofloxacine treatment: Treatment with this gyrase inhibitor resulted in an
increase of the CsA-trough-levels (+52 25%) and a decrease of the
volume of distribution (23 18%). The relative bioavailability im-
proved to 40% (6.4—99.5%) while the clearance decreased by 20
13.4%. CsA peak levels increased to 25.4% (0—80%). The alpha period
was reduced to 18 11.5%, while the beta elimination phase showed no
clear pattern of change. Conclusions: Increased CsA trough levels
under treatment with aminopenicillins and ofloxacine primarily result in
an improvement of the bioavailability of the immunosuppressant.
Exactly how aminopenicillins influence CsA metabolism remains un-
clear. The hepatic metabolism of ofloxacine gives an explanation for the
changes in CsA pharmacokinetics. If a long-term treatment with these
antibiotics is intended, short-term CsA monitoring is necessary, in case
of doubt pharmacokinetic studies must be done.
Amino and keto acids in serum of children with CRF under protein
balanced diet without and with supplementation of keto acids in connec-
tion with alimentary amino acids supply. M. Wigger, H.J. Stolpe, W.
Heine, K. Langer, Rostock University Children's Clinic, Research
Institut for Experimental Nutrition, Erlangen, Germany. The pattern of
the three branched-chain keto acids (BCKA) and the nine essential
amino acids in serum (including his) was measured in seven children
aged 6.5 to 17 years suffering from chronic renal failure. The investiga-
tion was made under protein balanced diet (PBD) containing 1.16
g/kglday protein and a protein balanced diet (PBDK) supplemented with
a mixture of essential amino acids or their keto analogues (EAA/KA)
and containing 1.08 g/kg/day protein and 0.22—0.27 g/kglday EAA/KA,
respectively. The alimentary supply of amino acids was analyzed
simultaneously. The low serum keto acids level, as known in CRF,
increased during the PBDK period. Essential amino acid level were not
affected by either diet. The original valine, histidine, threonine, tryp-
tophan and lysine deficiencies remained unchanged. The lysine, threo-
nine, tryptophan and histidine intake was found to be in the lower limit.
The results are discussed and recommendations are given.
99mTc.MAG3 compared with '31J-OIH in patients with normal and
impaired renal function. M. Wilfling, U. Keske, M. Cordes, R. Felix, G.
Gahl, Departments of Nephrology and Radiology, Free University
Berlin, Berlin, Germany. ssmTcmercaptoacetyltriglycifle (MAG3) is a
new radiopharmaceutical with similar biokinetic properties to '31J-o-
iodohippurate (OIH), but with a better imaging quality and logistical
advantages. In SO patients (20 of them with impaired renal function) the
renal clearances of MAG3 and OIH were compared by simultaneous
measurement. In another 20 patients (7 of them with impaired renal
function), the images, time-activity curves and the relative function of
right and left kidney were compared. With regard to the clearances,
good correlation (r — 0.95, P < l0) with a mean ratio MAG3-/OIH-
clearance of 0.62 was found. No significant difference between patients
with normal and impaired renal function could be demonstrated. An
influence of plasma protein, heomglobin and urine protein could be
excluded. The correlation coefficient of the 20 time-activity curves was
r = 0.92 (P < l0). Further, the images of MAG3 showed more details
due to higher resolution. It is concluded that MAG3 should be the
preferable substance for renograms in clinical routine over OIH.
Hypertonic stress-induced K accumulation in renal epithelial (MDCK)
cells. L. Wojnowski, H. Oberleithner, Inst itut of Physiology, University
of Wuerzburg, Wuerzburg, Germany. Collecting duct cells are usually
exposed to rapid changes in extracellular osmolarity, depending on the
state of hydratation. These changes are compensated by excretion or
accumulation of osmotically active substances. We investigated mech-
anisms of regulatory volume increase (RVI) in fused MDCK cells, a cell
line originally derived from canine collecting duct. The intracellular ion
concentrations as well as the concentration of the volume marker
tetramethylammonium were measured by means of ion-selective
microelectrodes. The application of the hypertonic Ringer solution (5
mm; + 150 mmol/liter mannitol) resulted in a cell shrinkage to 84 2%
of the initial cell volume (shrinkage expected for an ideal osmometer
would be 66% of the initial cell volume). Therefore, the calculated RVI
was 53%. The intracellular K concentration increased under these
conditions from 132 4 to 219 7 mmol/liter (N = 18). Ouabain (0.1
mmollliter) as well as amiloride (1 mmol/liter) reduced K accumulation
significantly (P < 0.001), whereas the H-K1-ATPase inhibitor SCH
28080 had no effect. The intracellular C1 concentration (58 2
mmol/liter; N = 18) rose to 113 6 mmollliter (N = 9). During the first
90 seconds of the hypertonic stress, a transient increase in intracellular
Na' and HCO concentrations was observed (from 6 0.6 to 9 0.9
mmol/liter, N = 21, and from 22 0.6 to 35 1.3 mmollliter, N = 9,
respectively). We conclude that epithelial cells of the collecting duct
regulate their volume in hypertonic stress by accumulation of KCI. The
K' accumulation is mediated by Na-K-ATPase. This enzyme is
activated by Na ions, which are transported into the cells by the
Na4'-H4 antiporter.
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Are transients of intracellular Ca2' upon constrictor stimulation of
mesangial cells all-or-none responses? S. Zamel, C.P. Bdhrle, R. Nobil-
ing, I. Physiologisches Institut der Universitat Heidelberg, Heidelberg,
Germany. Measurements of intracellular free calcium in individual
cultured glomerular mesangial cells (rat, MCs) were performed using a
microscope fluorimeter with dual wavelength UV-excitation of the
Ca2-sensitive dye fura-2, and extremely sensitive, photon counting-
based light detection. Fast (up to 200 x s') filter changes allow
quasi-continuous measurements at different wavelengths (Nobiling and
Bührle, J Micr 156:149—161, 1989). Cultured MCs are frequently used as
models for the closely related vascular smooth muscle cells (VSMCs)
and, in some instances, of the granulated renin producing cells in the
media of the afferent arterioles. The important role of Ca2 as a
messenger for controlling renin secretion or contraction, is widely
accepted. However, many details of the stimulus transmission are still
unclear and subject to extensive work. We report here characteristics of
the Ca2 transients that occur in cultured MCs, but also in VSMCs after
the application of the vasoactive peptides AVP and Ang II. Our data
indicate that between iO to l0— mol x l there is nearly no
influence of the agonist concentration on the shape and the height of the
observed Ca2 transients. Additionally, a delayed cellular reaction after
the application of the agonist is observed. This delay is not only
dependent on the concentration of the agonists, but also on the
temperature. The findings may have significance in a discussion,
whether or not cellular oscillators play a role in controlling MC or
VSMC function.
Hemihypertrophy and medullary sponge kidney—A common finding?
M. Zeier, D. Fliser, H.P. Barth, E. Ritz, Departments of Medicine and
Nephrology, University of Heidelberg, Heidelberg, Germany. It is
known from the literature that hemihypertrophy and medullary sponge
kidney are associated in rare cases. The probability of the association is
5% as estimated in a paper from Harris (Urology 1980). In the
outpatient clinic of the renal unit (University Hospital of Heidelberg)
we diagnosed nine consecutive cases of medullary sponge kidney.
Diagnosis was made by calcium nephrolithiasis and segmental collect-
ing duct ectasia (intravenous urogram). No less than three patients
(30%) with medullary sponge kidney had hemihypertrophy. Hemihy-
pertrophy was in all cases left sided (1.5 to 4 cm lower limb-length
difference), while the kidneys were affected equally. Recently an
association between prenatal thalidomid exposure and hemihypertro-
phy was quoted, interestingly kidney and limb development starts
around day 30 in embryonal period. In all three cases thalidomid
exposure cannot be excluded. Conclusion: Hemihypertrophy and med-
ullary sponge kidney are more frequently associated than expected.
Acute renal failure and hantavirus infection—24 clinical cases. M.
Zeier, L. Zäller, J. Bartel, W. HauJimann, E. Ritz, Departments of
Medicine and Nephrology, University of Heidelberg, Heidelberg, Ger-
many. The hantavirus, a single stranded RNA virus, is the well known
agent of the so-called hemorrhagic fever with renal syndrome (HFRS).
Approximately 5 to 10% of nontraumatic acute renal failure (ARF)
episodes in the Federal Republic of Germany are hantavirus induced.
Until recently laboratory diagnosis was limited because the immuno-
fluorescence test required special precaution. At the present time a new
ELISA test with recombinant nucleocapsid antigen is available. Since
1985 24 cases of HFRS were clinically and serologically diagnosed,
among them 8 patients in 1989, due to an improved serological tech-
nique. The majority of the patients (22/24) were located in southwest
Germany. An endemic area south of Stuttgart was identified, were no
less than 6 HFRS cases were seen and the seroprevalence in the general
population was 3.73% (in comparison to <1% in the general population
of a larger city). The majority of patients were male (21/24) and young
(median age 38 years). Most of the patients had oliguria, 9/24 required
temporarily hemodialysis. All of the 24 patients had normal renal
function after the HFRS episode. Seven of the 24 patients had renal
biopsy with interstitial nephritis in 5 cases and mesangial-proliferative
glomerulonephritis in 2 cases. Conclusions: (1) HFRS is an important
and common cause of HFRS. (2) The clinical course and outcome are
similar to the Scandinavian nephropathia epidemica. (3) Recombinant
antigen allows a safe and fast diagnosis.
